<SEC-DOCUMENT>0001096906-21-001665.txt : 20210722
<SEC-HEADER>0001096906-21-001665.hdr.sgml : 20210722
<ACCEPTANCE-DATETIME>20210722125739
ACCESSION NUMBER:		0001096906-21-001665
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20210722
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210722
DATE AS OF CHANGE:		20210722

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UTAH MEDICAL PRODUCTS INC
		CENTRAL INDEX KEY:			0000706698
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				870342734
		STATE OF INCORPORATION:			UT
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-12575
		FILM NUMBER:		211106798

	BUSINESS ADDRESS:	
		STREET 1:		7043 S 300 WEST
		CITY:			MIDVALE
		STATE:			UT
		ZIP:			84047
		BUSINESS PHONE:		8015661200
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>utmd-20210722.htm
<DESCRIPTION>UTAH MEDICAL PRODUCTS, INC. - FORM 8-K SEC FILING
<TEXT>
<XBRL>
<?xml version='1.0' encoding='us-ascii' standalone='no'?>
<html xmlns='http://www.w3.org/1999/xhtml' xmlns:xbrli='http://www.xbrl.org/2003/instance' xmlns:dei='http://xbrl.sec.gov/dei/2020-01-31' xmlns:i='http://www.xbrl.org/2003/instance' xmlns:xbrldi='http://xbrl.org/2006/xbrldi' xmlns:iso4217='http://www.xbrl.org/2003/iso4217' xmlns:ix='http://www.xbrl.org/2013/inlineXBRL' xmlns:ixt='http://www.xbrl.org/inlineXBRL/transformation/2015-02-26' xmlns:ixt-sec='http://www.sec.gov/inlineXBRL/transformation/2015-08-31' xmlns:utr='http://www.xbrl.org/2009/utr' xmlns:link='http://www.xbrl.org/2003/linkbase' xmlns:xlink='http://www.w3.org/1999/xlink' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance'>
<head>
<!-- Produced by EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2021 [PPXK5GW761L0VF08S1AD]. www.edgarsuite.com -->
<title>UTAH MEDICAL PRODUCTS, INC. - Form 8-K SEC filing</title>
<meta content='text/html; charset=UTF-8' http-equiv='Content-Type' />
</head>
<body>
<div style='display:none'>
<ix:header>
<ix:hidden>
<ix:nonNumeric name='dei:EntityCentralIndexKey' contextRef='D210722' id='fact1'>0000706698</ix:nonNumeric>
<ix:nonNumeric name='dei:AmendmentFlag' contextRef='D210722' id='fact2'>false</ix:nonNumeric>
</ix:hidden>
<ix:references>
<link:schemaRef xlink:arcrole='http://www.xbrl.org/2003/linkbase' xlink:href='utmd-20210722.xsd' xlink:type='simple'/>
</ix:references>
<ix:resources>
<i:context id='D210722'>
<i:entity>
<i:identifier scheme='http://www.sec.gov/CIK'>0000706698</i:identifier>
</i:entity>
<i:period>
<i:startDate>2021-07-22</i:startDate>
<i:endDate>2021-07-22</i:endDate>
</i:period>
</i:context>
</ix:resources>
</ix:header>
</div>
<div style='margin-left:72pt;width:468pt'><hr style='border:0;height:0;width:0;margin:14pt 0 0 0'/><p style='font:14pt Times New Roman;margin:0;text-align:center'><b>UNITED STATES </b></p>
<p style='font:14pt Times New Roman;margin:0;text-align:center'><b>SECURITIES AND EXCHANGE COMMISSION</b></p>
<p style='font:15pt Times New Roman;margin:0;text-align:center'><b>Washington, D.C. &#160;20549</b></p>
<p style='font:15pt Times New Roman;margin:0;text-align:center'>&#160;</p>
<p style='font:14pt Times New Roman;margin:0;text-align:center'><b>FORM <ix:nonNumeric name='dei:DocumentType' contextRef='D210722' escape='true'>8-K</ix:nonNumeric></b></p>
<p style='font:14pt Times New Roman;margin:0;text-align:center'>&#160;</p>
<p style='font:14pt Times New Roman;margin:0;text-align:center'><b>CURRENT REPORT</b></p>
<p style='font:14pt Times New Roman;margin:0;text-align:center'>&#160;</p>
<p style='font:12pt Times New Roman;margin:0;text-align:center'><b>Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</b></p>
<p style='font:11pt Times New Roman;margin:0;text-align:center'>&#160;</p>
<p style='font:14pt Times New Roman;margin:0;text-align:center'><span style='font-size:11pt'>Date of Report (date of earliest event reported): &#160;</span><ix:nonNumeric name='dei:DocumentPeriodEndDate' contextRef='D210722' format='ixt:datemonthdayyearen'>July 22, 2021</ix:nonNumeric></p>
<p style='font:11pt Times New Roman;margin:0;text-align:center'>&#160;</p>
<p style='font:11pt Times New Roman;margin:0;margin-right:72pt;text-align:justify'>&#160;</p>
<table style='border-collapse:collapse;width:468pt'><tr><td colspan='5' valign='top' style='width:468pt;padding-left:0.7pt;padding-right:0.7pt'><p style='font:10pt Times New Roman;margin:0;text-align:center'><span style='font-size:14pt'><b><ix:nonNumeric name='dei:EntityRegistrantName' contextRef='D210722' escape='true'>UTAH MEDICAL PRODUCTS, INC.</ix:nonNumeric></b></span></p>
</td></tr>
<tr><td colspan='5' valign='top' style='width:468pt;padding-left:0.7pt;padding-right:0.7pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>(Exact name of registrant as specified in its charter)</p>
</td></tr>
<tr><td valign='top' style='width:147.95pt;padding-left:0.7pt;padding-right:0.7pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:12.15pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:147.9pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:12.1pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:147.9pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td></tr>
<tr><td valign='top' style='width:147.95pt;padding-left:0.7pt;padding-right:0.7pt'><p style='font:10pt Times New Roman;margin:0;text-align:center'><span style='font-size:11pt'><b><ix:nonNumeric name='dei:EntityIncorporationStateCountryCode' contextRef='D210722' format='ixt-sec:stateprovnameen'>Utah</ix:nonNumeric></b></span></p>
</td><td valign='top' style='width:12.15pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:11pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:147.9pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:10pt Times New Roman;margin:0;text-align:center'><ix:nonNumeric name='dei:EntityFileNumber' contextRef='D210722' escape='true'>000-12575</ix:nonNumeric></p>
</td><td valign='top' style='width:12.1pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:11pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:147.9pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:10pt Times New Roman;margin:0;text-align:center'><span style='font-size:11pt'><b><ix:nonNumeric name='dei:EntityTaxIdentificationNumber' contextRef='D210722' escape='true'>87-0342734</ix:nonNumeric></b></span></p>
</td></tr>
<tr><td valign='top' style='width:147.95pt;padding-left:0.7pt;padding-right:0.7pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>(State or other jurisdiction of</p>
</td><td valign='top' style='width:12.15pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:147.9pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>(Commission File Number)</p>
</td><td valign='top' style='width:12.1pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:147.9pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>(IRS Employer</p>
</td></tr>
<tr><td valign='top' style='width:147.95pt;padding-left:0.7pt;padding-right:0.7pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>incorporation or organization)</p>
</td><td valign='top' style='width:12.15pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:147.9pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:12.1pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:147.9pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>Identification No.)</p>
</td></tr>
<tr><td valign='top' style='width:147.95pt;padding-left:0.7pt;padding-right:0.7pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:12.15pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:147.9pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:12.1pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:147.9pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td></tr>
<tr><td colspan='3' valign='top' style='width:308pt;padding-left:0.7pt;padding-right:0.7pt'><p style='font:10pt Times New Roman;margin:0;text-align:center'><ix:nonNumeric name='dei:EntityAddressAddressLine1' contextRef='D210722' escape='true'>7043 South 300 West</ix:nonNumeric></p>
</td><td valign='top' style='width:12.1pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:11pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:147.9pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:11pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td></tr>
<tr><td colspan='3' valign='top' style='width:308pt;padding-left:0.7pt;padding-right:0.7pt'><p style='font:11pt Times New Roman;margin:0;text-align:center'><span style='font-size:12pt'><b><ix:nonNumeric name='dei:EntityAddressCityOrTown' contextRef='D210722' escape='true'>Midvale</ix:nonNumeric></b><b>, </b><b><ix:nonNumeric name='dei:EntityAddressStateOrProvince' contextRef='D210722' format='ixt-sec:stateprovnameen'>Utah</ix:nonNumeric></b><b> </b></span></p>
</td><td valign='top' style='width:12.1pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:11pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:147.9pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:10pt Times New Roman;margin:0;text-align:center'><span style='font-size:12pt'><b><ix:nonNumeric name='dei:EntityAddressPostalZipCode' contextRef='D210722' escape='true'>84047</ix:nonNumeric></b></span></p>
</td></tr>
<tr><td colspan='3' valign='top' style='width:308pt;padding-left:0.7pt;padding-right:0.7pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>(Address of principal executive offices)</p>
</td><td valign='top' style='width:12.1pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:147.9pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>(Zip code)</p>
</td></tr>
<tr><td colspan='3' valign='top' style='width:308pt;padding-left:0.7pt;padding-right:0.7pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:12.1pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:147.9pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td></tr>
<tr><td colspan='3' valign='top' style='width:308pt;padding-left:0.7pt;padding-right:0.7pt'><p style='font:11pt Times New Roman;margin:0'>Registrant&#8217;s telephone number, including area code: &#160;</p>
</td><td valign='top' style='width:12.1pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:11pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:147.9pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:10pt Times New Roman;margin:0;text-align:center'><span style='font-size:12pt'><b>Phone: </b><b>(</b><b><ix:nonNumeric name='dei:CityAreaCode' contextRef='D210722' escape='true'>801</ix:nonNumeric></b><b>) </b><b><ix:nonNumeric name='dei:LocalPhoneNumber' contextRef='D210722' escape='true'>566-1200</ix:nonNumeric></b></span></p>
</td></tr>
<tr><td colspan='3' valign='top' style='width:308pt;padding-left:0.7pt;padding-right:0.7pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:12.1pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:147.9pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td></tr>
<tr><td colspan='5' valign='top' style='width:468pt;padding-left:0.7pt;padding-right:0.7pt'><p style='font:12pt Times New Roman;margin:0;text-align:center'><b>n/a</b></p>
</td></tr>
<tr><td colspan='5' valign='top' style='width:468pt;padding-left:0.7pt;padding-right:0.7pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>(Former name or former address, if changed since last report)</p>
</td></tr>
</table>
<p style='font:11pt Times New Roman;margin:0;margin-right:72pt;text-align:justify'>&#160;</p>
<p style='font:10pt Times New Roman;margin:0;text-align:justify'>Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>
<p style='font:10pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</div>
<div style='margin-left:72pt'><table style='border-collapse:collapse'><tr><td valign='top' style='width:27.9pt'><p style='font:10pt Times New Roman;margin:0;text-align:justify'><ix:nonNumeric name='dei:WrittenCommunications' contextRef='D210722' format='ixt-sec:boolballotbox'>&#9744;</ix:nonNumeric></p>
</td><td valign='top' style='width:450.9pt'><p style='font:10pt Times New Roman;margin:0;text-align:justify'>Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p>
</td></tr>
<tr><td valign='top' style='width:27.9pt'><p style='font:10pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td><td valign='top' style='width:450.9pt'><p style='font:10pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td></tr>
<tr><td valign='top' style='width:27.9pt'><p style='font:10pt Times New Roman;margin:0;text-align:justify'><ix:nonNumeric name='dei:SolicitingMaterial' contextRef='D210722' format='ixt-sec:boolballotbox'>&#9744;</ix:nonNumeric></p>
</td><td valign='top' style='width:450.9pt'><p style='font:10pt Times New Roman;margin:0;text-align:justify'>Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p>
</td></tr>
<tr><td valign='top' style='width:27.9pt'><p style='font:10pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td><td valign='top' style='width:450.9pt'><p style='font:10pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td></tr>
<tr><td valign='top' style='width:27.9pt'><p style='font:10pt Times New Roman;margin:0;text-align:justify'><ix:nonNumeric name='dei:PreCommencementTenderOffer' contextRef='D210722' format='ixt-sec:boolballotbox'>&#9744;</ix:nonNumeric></p>
</td><td valign='top' style='width:450.9pt'><p style='font:10pt Times New Roman;margin:0;text-align:justify'>Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p>
</td></tr>
<tr><td valign='top' style='width:27.9pt'><p style='font:10pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td><td valign='top' style='width:450.9pt'><p style='font:10pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td></tr>
<tr><td valign='top' style='width:27.9pt'><p style='font:10pt Times New Roman;margin:0;text-align:justify'><ix:nonNumeric name='dei:PreCommencementIssuerTenderOffer' contextRef='D210722' format='ixt-sec:boolballotbox'>&#9744;</ix:nonNumeric></p>
</td><td valign='top' style='width:450.9pt'><p style='font:10pt Times New Roman;margin:0;text-align:justify'>Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p>
</td></tr>
<tr><td valign='top' style='width:27.9pt'><p style='font:10pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td><td valign='top' style='width:450.9pt'><p style='font:10pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td></tr>
<tr><td colspan='2' valign='top' style='width:478.8pt'><p style='font:10pt Times New Roman;margin:0;text-align:justify'>Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (Section 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (Section 240.12b-2 of this chapter).</p>
</td></tr>
<tr><td valign='top' style='width:27.9pt'><p style='font:10pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td><td valign='top' style='width:450.9pt'><p style='font:10pt Times New Roman;margin:0;text-align:right'>Emerging growth company <ix:nonNumeric name='dei:EntityEmergingGrowthCompany' contextRef='D210722' format='ixt-sec:boolballotbox'>&#9744;</ix:nonNumeric></p>
</td></tr>
<tr><td colspan='2' valign='top' style='width:478.8pt'><p style='font:10pt Times New Roman;margin:0'>&#160;</p>
</td></tr>
<tr><td colspan='2' valign='top' style='width:478.8pt'><p style='font:10pt Times New Roman;margin:0'>If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [&#160;&#160;]</p>
</td></tr>
</table>
</div>
<div style='margin-left:72pt;width:468pt'><hr style='border:0;height:0;width:0;margin:14pt 0 0 0'/><hr style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'/><p style='line-height:0;margin:0'></p>
<hr style='border:0;height:0;width:0;margin:14pt 0 0 0'/><p style='font:11pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
<p style='font:11pt Times New Roman;margin:0'><b>ITEM 2.02&#8212;RESULTS OF OPERATIONS AND FINANCIAL CONDITION</b></p>
<p style='font:11pt Times New Roman;margin:0;text-align:center'>&#160;</p>
<p style='font:12pt Times New Roman;margin:0;margin-left:90pt'>Attached hereto as Exhibit 99.1 and incorporated by reference herein is financial information for Utah Medical Products, Inc. for the three months ended June 30, 2021 and forward-looking statements relating to 2021 and beyond as presented in a press release dated July 22, 2021. &#160;The information in this report shall be deemed incorporated by reference into any registration statement heretofore or hereafter filed under the Securities Act of 1933, as amended, except to the extent that such information is superseded by information as of a subsequent date that is included in or incorporated by reference into such registration statement. The information in this report shall not be treated as filed for purposes of the Securities Exchange Act of 1934, as amended.</p>
<p style='font:11pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
<p style='font:11pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
<p style='font:11pt Times New Roman;margin:0'><b>ITEM 9.01&#8212;FINANCIAL STATEMENTS AND EXHIBITS</b></p>
<p style='font:11pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
<p style='font:11pt Times New Roman;margin:0;text-align:justify'>The following is filed as an exhibit to this report: &#160;</p>
<p style='font:11pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</div>
<div style='margin-left:72pt'><table style='border-collapse:collapse;width:476pt'><tr><td valign='top' style='width:59.75pt;padding-left:5.75pt;padding-right:5.75pt;border-bottom:0.5pt solid #000000'><p style='font:9pt Times New Roman;margin:0;text-align:center'><b>Exhibit</b></p>
<p style='font:9pt Times New Roman;margin:0;text-align:center'><b>Number*</b></p>
</td><td valign='top' style='width:12.5pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:329.5pt;padding-left:5.75pt;padding-right:5.75pt;border-bottom:0.5pt solid #000000'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
<p style='font:9pt Times New Roman;margin:0;text-align:center'><b>Title of Document</b></p>
</td><td valign='top' style='width:12.5pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:61.75pt;padding-left:5.75pt;padding-right:5.75pt;border-bottom:0.5pt solid #000000'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
<p style='font:9pt Times New Roman;margin:0;text-align:center'><b>Location</b></p>
</td></tr>
<tr><td valign='top' style='width:59.75pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:11pt Times New Roman;margin:0;text-align:center'><b>Item 99.1</b></p>
</td><td valign='top' style='width:12.5pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:11pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td><td valign='top' style='width:329.5pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:11pt Times New Roman;margin:0;text-align:justify'><span style='font-size:12pt;color:#0000FF;border-bottom:1px solid #0000FF'><a href='utah_ex99z1.htm' style='text-decoration:none'>Financial information for Utah Medical Products, Inc. for the three months ended </a><a href='utah_ex99z1.htm' style='text-decoration:none'>June 30, </a><a href='utah_ex99z1.htm' style='text-decoration:none'>2021</a><a href='utah_ex99z1.htm' style='text-decoration:none'> and forward-loo</a><a href='utah_ex99z1.htm' style='text-decoration:none'>king statements relating to 2021</a><a href='utah_ex99z1.htm' style='text-decoration:none'> and beyond as presented in </a><a href='utah_ex99z1.htm' style='text-decoration:none'>a press release dated July 22</a><a href='utah_ex99z1.htm' style='text-decoration:none'>, 2021</a></span><span style='font-size:12pt'>.</span></p>
</td><td valign='top' style='width:12.5pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:11pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td><td valign='top' style='width:61.75pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:11pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td></tr>
<tr><td valign='top' style='width:59.75pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:11pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:12.5pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:11pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td><td valign='top' style='width:329.5pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:11pt Times New Roman;margin:0'>&#160;</p>
</td><td valign='top' style='width:12.5pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:11pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td><td valign='top' style='width:61.75pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:11pt Times New Roman;margin:0;text-align:justify'>This filing</p>
</td></tr>
<tr><td valign='top' style='width:59.75pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:11pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:12.5pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:11pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td><td valign='top' style='width:329.5pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:11pt Times New Roman;margin:0'>&#160;</p>
</td><td valign='top' style='width:12.5pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:11pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td><td valign='top' style='width:61.75pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:11pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td></tr>
</table>
</div>
<div style='margin-left:72pt;width:468pt'><p style='font:11pt Times New Roman;margin:0;text-indent:-18pt;margin-left:18pt;text-align:justify'>_______________________________________</p>
<p style='font:9pt Times New Roman;margin-top:6pt;margin-bottom:0pt;margin-left:18pt;text-align:justify'><kbd style='position:absolute;font:9pt Times New Roman;margin-left:-18pt'>*</kbd>All exhibits are numbered with the number preceding the decimal indicating the applicable SEC reference number in Item 601 and the number following the decimal indicating the sequence of the particular document. &#160;</p>
<p style='font:11pt Times New Roman;margin-top:6pt;margin-bottom:0pt;text-indent:-18pt;margin-left:18pt;text-align:justify'>&#160;</p>
<p style='font:11pt Times New Roman;margin:0;text-align:center'><b>SIGNATURES</b></p>
<p style='font:11pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
<p style='font:11pt Times New Roman;margin:0;text-align:justify'>Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>
<p style='font:11pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</div>
<div style='margin-left:72pt'><table style='border-collapse:collapse'><tr><td valign='top' style='width:234.05pt'><p style='font:11pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td><td colspan='2' valign='top' style='width:244.75pt;padding-left:0.7pt;padding-right:5.75pt'><p style='font:11pt Times New Roman;margin:0;text-align:justify'><b>UTAH MEDICAL PRODUCTS, INC.</b></p>
</td></tr>
<tr><td valign='top' style='width:234.05pt'><p style='font:11pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td><td colspan='2' valign='top' style='width:244.75pt;padding-left:0.7pt;padding-right:5.75pt'><p style='font:11pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td></tr>
<tr><td valign='top' style='width:234.05pt'><p style='font:11pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td><td colspan='2' valign='top' style='width:244.75pt;padding-left:0.7pt;padding-right:5.75pt'><p style='font:11pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td></tr>
<tr><td valign='top' style='width:234.05pt'><p style='font:11pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td><td colspan='2' valign='top' style='width:244.75pt;padding-left:0.7pt;padding-right:5.75pt'><p style='font:11pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td></tr>
<tr><td valign='top' style='width:234.05pt'><p style='font:11pt Times New Roman;margin:0;text-align:justify'>Dated:  July 22, 2021</p>
</td><td valign='top' style='width:26.7pt;padding-left:0.7pt;padding-right:5.75pt'><p style='font:11pt Times New Roman;margin:0;text-align:justify'>By:</p>
</td><td valign='top' style='width:218.05pt;border-bottom:0.5pt solid #000000'><p style='font:11pt Times New Roman;margin:0;text-align:justify'>/s/ Kevin L. Cornwell</p>
</td></tr>
<tr><td valign='top' style='width:234.05pt'><p style='font:11pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td><td valign='top' style='width:26.7pt;padding-left:0.7pt;padding-right:5.75pt'><p style='font:11pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td><td valign='top' style='width:218.05pt;border-top:0.5pt solid #000000'><p style='font:11pt Times New Roman;margin:0;text-align:justify'>Kevin L. Cornwell, Chief Executive Officer</p>
</td></tr>
</table>
</div>
<div style='margin-left:72pt;width:468pt'><hr style='border:0;height:0;width:0;margin:14pt 0 0 0'/></div>
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>utah_ex99z1.htm
<DESCRIPTION>FINANCIAL INFORMATION
<TEXT>
<HTML>
<!-- Produced by EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2021 [PPXK5GW761L0VF08S1AD]. www.edgarsuite.com -->
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>
<DIV style=margin-left:72pt;width:468pt><HR style='border:0;height:0;width:0;margin:14pt 0 0 0'><P align=center style='font:11pt Times New Roman;margin:0'><B>EXHIBIT 99.1</B></P>
<P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0;margin-right:-6.3pt'><B>UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2021</B></P>
<P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;font:11pt Times New Roman;margin-left:0pt'>Contact: Crystal Rios (801) 566-1200</KBD><KBD style=margin-left:360pt></KBD>July 22, 2021&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>Salt Lake City, Utah &#8211;&nbsp;The second calendar quarter (2Q) of 2021 financial results were dramatically different from 2Q 2020 because 2Q 2020 results were the low point of Utah Medical Products, Inc.&#8217;s (Nasdaq: UTMD) performance during the COVID-19 pandemic, during a time when there were restrictions on so-called nonessential medical procedures. Therefore, UTMD management reports quarterly income statement results compared to the same periods not only in 2021 compared to 2020, but also compared to 2019. The Company&#8217;s stated objective in 2021 has been to try to fully recover back to its 2019 financial performance. Please see the income statements for all three years on the last page. &nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>Currencies in this release are denoted as $ or USD = U.S. Dollars; AUD = Australia Dollars; &#163;&nbsp;or GBP = UK Pound Sterling; C$ or CAD = Canadian Dollars; and &#8364;&nbsp;or EUR = Euros. Currency amounts throughout this report are in thousands, except per share amounts and where noted. &nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>Overview of Results</FONT></P>
<P style='font:11pt Times New Roman;margin:0'>The following summary comparison of 2Q and first half (1H) 2021 with 2Q and 1H 2020 income statement measures demonstrates UTMD&#8217;s excellent recovery, despite many new challenges:</P>
<P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;font:11pt Times New Roman;margin-left:198pt'> 2Q</KBD><KBD style=margin-left:270pt></KBD> &nbsp;&nbsp;1H&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;font:11pt Times New Roman;margin-left:180pt'> <FONT style='border-bottom:1px solid #000000'>(April &#8211;&nbsp;June)</FONT></KBD><KBD style=margin-left:252pt></KBD> &nbsp;&nbsp;<FONT style='border-bottom:1px solid #000000'>(January-June)</FONT>&nbsp;</P>
<TABLE style=border-collapse:collapse;width:450pt;margin-left:27.9pt><TR><TD valign=top style=width:130.5pt><P style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>Revenues (Sales):</P>
</TD><TD valign=top style=width:112.5pt><P style='font:11pt Times New Roman;margin:0;text-indent:30.6pt;margin-right:-6.3pt'>+ &nbsp;&nbsp;43%</P>
</TD><TD valign=top style=width:90pt><P style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>+ &nbsp;&nbsp;20%</P>
</TD><TD valign=top style=width:117pt><P style='font:11pt Times New Roman;margin:0;text-indent:17.1pt;margin-right:-6.3pt'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:130.5pt><P style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>Gross Profit (GP):</P>
</TD><TD valign=top style=width:112.5pt><P style='font:11pt Times New Roman;margin:0;text-indent:30.6pt;margin-right:-6.3pt'>+ &nbsp;&nbsp;57%</P>
</TD><TD valign=top style=width:90pt><P style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>+ &nbsp;&nbsp;25%</P>
</TD><TD valign=top style=width:117pt><P style='font:11pt Times New Roman;margin:0;text-indent:17.1pt;margin-right:-6.3pt'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:130.5pt><P style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>Operating Income (OI):</P>
</TD><TD valign=top style=width:112.5pt><P style='font:11pt Times New Roman;margin:0;text-indent:30.6pt;margin-right:-6.3pt'>+ 141% </P>
</TD><TD valign=top style=width:90pt><P style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>+ &nbsp;&nbsp;48% </P>
</TD><TD valign=top style=width:117pt><P style='font:11pt Times New Roman;margin:0;text-indent:17.1pt;margin-right:-6.3pt'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:130.5pt><P style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>Income Before Tax (EBT):</P>
<P style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>Net Income (NI):</P>
</TD><TD valign=top style=width:112.5pt><P style='font:11pt Times New Roman;margin:0;text-indent:30.6pt;margin-right:-6.3pt'>+ 144% </P>
<P style='font:11pt Times New Roman;margin:0;text-indent:30.6pt;margin-right:-6.3pt'>+ 161%</P>
</TD><TD valign=top style=width:90pt><P style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>+ &nbsp;&nbsp;46% </P>
<P style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>+ &nbsp;&nbsp;45%</P>
</TD><TD valign=top style=width:117pt><P style='font:11pt Times New Roman;margin:0;text-indent:17.1pt;margin-right:-6.3pt'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:130.5pt><P style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>Earnings Per Share (EPS):</P>
</TD><TD valign=top style=width:112.5pt><P style='font:11pt Times New Roman;margin-top:0pt;margin-bottom:6pt;text-indent:30.6pt;margin-right:-6.5pt'>+ 161%</P>
</TD><TD valign=top style=width:90pt><P style='font:11pt Times New Roman;margin-top:0pt;margin-bottom:6pt;margin-right:-6.5pt'>+ &nbsp;&nbsp;46%</P>
</TD><TD valign=top style=width:117pt><P style='font:11pt Times New Roman;margin-top:0pt;margin-bottom:6pt;text-indent:17.1pt;margin-right:-6.5pt'>&nbsp;</P>
</TD></TR>
</TABLE>
<P style='font:11pt Times New Roman;margin:0;margin-right:-6.5pt'>The above increases in NI and EPS according to U.S. Generally Accepted Accounting Principles (US GAAP) were affected by long term deferred tax liability (DTL) increases on the balance of Femcare identifiable intangible assets (IIA) in both 2Q 2020 and 2Q 2021. As stockholders may remember, the DTL was initiated as of the 2011 acquisition of Femcare because the expense from amortizing Femcare IIA, most of which is occurring over a fifteen year time span from the acquisition date, is not tax-deductible in the UK. According to US GAAP, the future tax impact of a change in DTL must be recognized in the quarter in which a tax law change is enacted. In 2Q 2020, a $225 increase in deferred UK taxes over the next six years occurred because the UK decided to not reduce its corporate income tax rate from 19% to 17% beginning in 2Q 2020, as was previously enacted. This year in 2Q 2021, another $390 increase in DTL over the remaining five years occurred because in June 2021, UK parliament ratified the Finance Minister&#8217;s plan to increase the UK corporate income tax rate from 19% to 25% beginning on April 1, 2023, which affects the deferred taxes for IIA to be amortized after April 1 2023 until fully amortized as of 1Q 2026.</P>
<P style='font:11pt Times New Roman;margin-top:6pt;margin-bottom:0pt;margin-right:-6.5pt'>UTMD management believes that the presentation of results excluding the unfavorable deferred tax liability adjustments to its 2Q and 1H 2021 and 2Q and 1H 2020 income tax provisions provide meaningful supplemental information to both management and investors that is more clearly indicative of UTMD&#8217;s operating results. The non-US GAAP exclusion only affects Net Income and Earnings Per Share.</P>
<P style='font:11pt Times New Roman;margin:0;margin-right:-6.5pt'>Excluding the 2Q 2020 and 2Q 2021 deferred tax liability increases and resulting &#8220;one-time&#8221; tax provision increases due to the UK income tax rate changes, the resulting non-US GAAP NI and EPS changes follow: </P>
<P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;font:11pt Times New Roman;margin-left:162pt'>2Q</KBD><KBD style=margin-left:234pt></KBD> &nbsp;&nbsp;1H&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;font:11pt Times New Roman;margin-left:144pt'><FONT style='border-bottom:1px solid #000000'>(April &#8211;&nbsp;June)</FONT></KBD><KBD style=margin-left:216pt></KBD> &nbsp;&nbsp;<FONT style='border-bottom:1px solid #000000'>(January-June)</FONT>&nbsp;</P>
<TABLE style=border-collapse:collapse;width:276.9pt;margin-left:18.9pt><TR><TD valign=top style=width:139.5pt><P style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>NI (non-US GAAP):</P>
</TD><TD valign=top style=width:73.3pt><P style='font:11pt Times New Roman;margin:0;text-indent:-5.4pt;margin-right:-6.3pt'>+ 148%</P>
</TD><TD valign=top style=width:64.1pt><P style='font:11pt Times New Roman;margin:0;text-indent:-9.35pt;margin-right:-6.3pt'> &nbsp;&nbsp;&nbsp;+ 46%</P>
</TD></TR>
<TR><TD valign=top style=width:139.5pt><P style='font:11pt Times New Roman;margin:0;margin-left:-5.4pt;margin-right:-6.3pt'> &nbsp;EPS (non-US GAAP):</P>
</TD><TD valign=top style=width:73.3pt><P style='font:11pt Times New Roman;margin:0;text-indent:-5.4pt;margin-right:-6.3pt'>+ 148%</P>
</TD><TD valign=top style=width:64.1pt><P style='font:11pt Times New Roman;margin:0;text-indent:-5.4pt;margin-right:-6.5pt'> &nbsp;&nbsp;+ 48%</P>
</TD></TR>
</TABLE>
<P style='font:11pt Times New Roman;margin-top:6pt;margin-bottom:0pt'>Setting aside the abnormal year of 2020, a comparison of 2Q and 1H <FONT style='border-bottom:1px solid #000000'>2021</FONT> with 2Q and 1H <FONT style='border-bottom:1px solid #000000'>2019</FONT> income statement measures prior to the COVID-19 pandemic follows:</P>
<HR style='border:0;height:0;width:0;margin:14pt 0 0 0'><HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P style=line-height:0;margin:0></P>
<HR style='border:0;height:0;width:0;margin:14pt 0 0 0'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;font:11pt Times New Roman;margin-left:198pt'> 2Q</KBD><KBD style=margin-left:270pt></KBD> &nbsp;&nbsp;1H&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;font:11pt Times New Roman;margin-left:180pt'> <FONT style='border-bottom:1px solid #000000'>(April &#8211;&nbsp;June)</FONT></KBD><KBD style=margin-left:252pt></KBD> &nbsp;&nbsp;<FONT style='border-bottom:1px solid #000000'>(January-June)</FONT>&nbsp;</P>
<TABLE style=border-collapse:collapse;width:450pt;margin-left:27.9pt><TR><TD valign=top style=width:130.5pt><P style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>Revenues (Sales):</P>
</TD><TD valign=top style=width:112.5pt><P style='font:11pt Times New Roman;margin:0;text-indent:30.6pt;margin-right:-6.3pt'>+ &nbsp;6%</P>
</TD><TD valign=top style=width:90pt><P style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>+ &nbsp;4%</P>
</TD><TD valign=top style=width:117pt><P style='font:11pt Times New Roman;margin:0;text-indent:17.1pt;margin-right:-6.3pt'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:130.5pt><P style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>Gross Profit (GP):</P>
</TD><TD valign=top style=width:112.5pt><P style='font:11pt Times New Roman;margin:0;text-indent:30.6pt;margin-right:-6.3pt'>+ &nbsp;4%</P>
</TD><TD valign=top style=width:90pt><P style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>+ &nbsp;3%</P>
</TD><TD valign=top style=width:117pt><P style='font:11pt Times New Roman;margin:0;text-indent:17.1pt;margin-right:-6.3pt'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:130.5pt><P style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>Operating Income (OI):</P>
</TD><TD valign=top style=width:112.5pt><P style='font:11pt Times New Roman;margin:0;text-indent:30.6pt;margin-right:-6.3pt'>+ &nbsp;6% </P>
</TD><TD valign=top style=width:90pt><P style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>+ &nbsp;1% </P>
</TD><TD valign=top style=width:117pt><P style='font:11pt Times New Roman;margin:0;text-indent:17.1pt;margin-right:-6.3pt'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:130.5pt><P style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>Income Before Tax (EBT):</P>
<P style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>Net Income (NI):</P>
</TD><TD valign=top style=width:112.5pt><P style='font:11pt Times New Roman;margin:0;text-indent:30.6pt;margin-right:-6.3pt'>+ &nbsp;6% </P>
<P style='font:11pt Times New Roman;margin:0;text-indent:30.6pt;margin-right:-6.3pt'> ( 3%)</P>
</TD><TD valign=top style=width:90pt><P style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>+ &nbsp;0% </P>
<P style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'> &nbsp;( 3%)</P>
</TD><TD valign=top style=width:117pt><P style='font:11pt Times New Roman;margin:0;text-indent:17.1pt;margin-right:-6.3pt'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:130.5pt><P style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>Earnings Per Share (EPS):</P>
</TD><TD valign=top style=width:112.5pt><P style='font:11pt Times New Roman;margin:0;text-indent:30.6pt;margin-right:-6.3pt'> ( 1%)</P>
</TD><TD valign=top style=width:90pt><P style='font:11pt Times New Roman;margin-top:0pt;margin-bottom:6pt;margin-right:-6.5pt'> &nbsp;( 1%)</P>
</TD><TD valign=top style=width:117pt><P style='font:11pt Times New Roman;margin-top:0pt;margin-bottom:6pt;text-indent:17.1pt;margin-right:-6.5pt'>&nbsp;</P>
</TD></TR>
</TABLE>
<P style='font:11pt Times New Roman;margin:0'>Since there was no UK tax law change enacted in 2019, a negative comparison of NI and EPS per US GAAP resulted. &nbsp;Excluding the 2Q 2021 enacted future tax rate change and DTL impact, a comparison of 2Q and 1H <FONT style='border-bottom:1px solid #000000'>2021</FONT> with 2Q and 1H <FONT style='border-bottom:1px solid #000000'>2019</FONT> NI and EPS follows:&nbsp; &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0;margin-left:180pt'><KBD style='position:absolute;font:11pt Times New Roman;margin-left:0pt'> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2Q</KBD><KBD style=margin-left:36pt></KBD> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1H&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;font:11pt Times New Roman;margin-left:180pt'> &nbsp;<FONT style='border-bottom:1px solid #000000'>(April &#8211;&nbsp;June)</FONT></KBD><KBD style=margin-left:252pt></KBD> &nbsp;&nbsp;&nbsp;<FONT style='border-bottom:1px solid #000000'>(January-June)</FONT>&nbsp;</P>
<TABLE style=border-collapse:collapse;width:316.1pt;margin-left:18.9pt><TR><TD valign=top style=width:171pt><P style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>NI (non-US GAAP):</P>
</TD><TD valign=top style=width:81pt><P style='font:11pt Times New Roman;margin:0;text-indent:-5.4pt;margin-right:-6.3pt'> &nbsp;+ &nbsp;&nbsp;8%</P>
</TD><TD valign=top style=width:64.1pt><P style='font:11pt Times New Roman;margin:0;text-indent:-9.35pt;margin-right:-6.3pt'> &nbsp;&nbsp;&nbsp;+ 3%</P>
</TD></TR>
<TR><TD valign=top style=width:171pt><P style='font:11pt Times New Roman;margin:0;margin-left:-5.4pt;margin-right:-6.3pt'> &nbsp;EPS (non-US GAAP):</P>
</TD><TD valign=top style=width:81pt><P style='font:11pt Times New Roman;margin:0;text-indent:-5.4pt;margin-right:-6.3pt'> &nbsp;+ 11%</P>
</TD><TD valign=top style=width:64.1pt><P style='font:11pt Times New Roman;margin:0;text-indent:-5.4pt;margin-right:-6.5pt'> &nbsp;&nbsp;+ 5%</P>
</TD></TR>
</TABLE>
<P style='font:11pt Times New Roman;margin-top:6pt;margin-bottom:0pt'>In brief, the 2Q and 1H 2021 financial results confirm that, after surviving a depression in its business in 2020, UTMD may be back on track, notwithstanding possible future restrictions on healthcare which benefits from the use of UTMD&#8217;s medical devices, or other consequences of government policies that may have a negative impact on the free market, medical device industry and small businesses in particular.</P>
<P style='font:11pt Times New Roman;margin-top:6pt;margin-bottom:0pt'>Sales in all product categories and almost all distribution channels were up substantially in 2Q and 1H 2021 compared to the same periods in 2020. Sales invoiced in foreign currencies, which represented 27% of total consolidated sales (when expressed in USD) during both 2Q 2021 and 1H 2021, were helped by a weaker USD. &nbsp;USD sales in 2Q and 1H 2021 were approximately 3% higher to that which would have resulted using the same foreign currency exchange (FX) rates as in the prior year&#8217;s same periods (&#8220;constant currency sales&#8221;). &nbsp;</P>
<P style='font:11pt Times New Roman;margin-top:6pt;margin-bottom:0pt'>Profit margins in 2Q and 1H 2021 compared to 2Q and 1H 2020 follow:</P>
<TABLE style=border-collapse:collapse;width:484.1pt;margin-left:-1.7pt><TR><TD valign=top style=width:232.1pt><P style='font:11pt Times New Roman;margin:0;text-indent:7.1pt;margin-right:-6.3pt'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0;text-indent:7.1pt;margin-right:-6.3pt'>&nbsp;</P>
</TD><TD valign=top style=width:63.8pt><P align=center style='font:11pt Times New Roman;margin:0;text-indent:7.1pt;margin-right:-6.3pt'>2Q 2021 </P>
<P align=center style='font:11pt Times New Roman;margin:0;text-indent:7.1pt;margin-right:-6.3pt'><FONT style='border-bottom:1px solid #000000'>(Apr &#8211;&nbsp;Jun)</FONT></P>
</TD><TD valign=top style='width:63.8pt;border-right:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0;text-indent:7.1pt;margin-right:-6.5pt'>2Q &nbsp;2020</P>
<P align=center style='font:11pt Times New Roman;margin:0;text-indent:7.1pt;margin-right:-6.5pt'><FONT style='border-bottom:1px solid #000000'>(Apr &#8211;&nbsp;Jun)</FONT></P>
</TD><TD valign=top style='width:63.75pt;border-left:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0;text-indent:7.1pt;margin-right:-6.5pt'>1H &nbsp;2021</P>
<P align=center style='font:11pt Times New Roman;margin:0;text-indent:7.1pt;margin-right:-6.5pt'><FONT style='border-bottom:1px solid #000000'>(Jan &#8211;&nbsp;Jun)</FONT></P>
</TD><TD valign=top style=width:60.65pt><P align=center style='font:11pt Times New Roman;margin:0;text-indent:7.1pt;margin-right:-6.5pt'>1H &nbsp;2020</P>
<P align=center style='font:11pt Times New Roman;margin:0;text-indent:7.1pt;margin-right:-6.5pt'><FONT style='border-bottom:1px solid #000000'>(Jan &#8211;&nbsp;Jun)</FONT></P>
</TD></TR>
<TR><TD valign=top style=width:232.1pt><P style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>Gross Profit Margin (GP/ sales):</P>
</TD><TD valign=top style=width:63.8pt><P align=center style='font:11pt Times New Roman;margin:0;text-indent:7.1pt;margin-right:-6.3pt'>61.8%</P>
</TD><TD valign=top style='width:63.8pt;border-right:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0;text-indent:7.1pt;margin-right:-6.3pt'>56.3% </P>
</TD><TD valign=top style='width:63.75pt;border-left:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0;text-indent:7.1pt;margin-right:-6.3pt'>62.5%</P>
</TD><TD valign=top style=width:60.65pt><P align=center style='font:11pt Times New Roman;margin:0;text-indent:7.1pt;margin-right:-6.3pt'>59.9%</P>
</TD></TR>
<TR><TD valign=top style=width:232.1pt><P style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>Operating Income Margin (OI/ sales):</P>
</TD><TD valign=top style=width:63.8pt><P align=center style='font:11pt Times New Roman;margin:0;text-indent:7.1pt;margin-right:-6.3pt'>37.8%</P>
</TD><TD valign=top style='width:63.8pt;border-right:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0;text-indent:7.1pt;margin-right:-6.3pt'>22.5%</P>
</TD><TD valign=top style='width:63.75pt;border-left:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0;text-indent:7.1pt;margin-right:-6.3pt'>36.7%</P>
</TD><TD valign=top style=width:60.65pt><P align=center style='font:11pt Times New Roman;margin:0;text-indent:7.1pt;margin-right:-6.3pt'>29.7%</P>
</TD></TR>
<TR><TD valign=top style=width:232.1pt><P style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>Net Income Margin &nbsp;(US GAAP)</P>
<P style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'><I>Net Income Margin (Non-US GAAP, B4 DTL Adj):</I></P>
</TD><TD valign=top style=width:63.8pt><P align=center style='font:11pt Times New Roman;margin:0;text-indent:7.1pt;margin-right:-6.3pt'>27.2%</P>
<P align=center style='font:11pt Times New Roman;margin:0;text-indent:7.1pt;margin-right:-6.3pt'><I>30.3% </I></P>
</TD><TD valign=top style='width:63.8pt;border-right:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0;text-indent:7.1pt;margin-right:-6.3pt'>14.9%</P>
<P align=center style='font:11pt Times New Roman;margin:0;text-indent:7.1pt;margin-right:-6.3pt'><I>17.5%</I></P>
</TD><TD valign=top style='width:63.75pt;border-left:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0;text-indent:7.1pt;margin-right:-6.3pt'>27.4%</P>
<P align=center style='font:11pt Times New Roman;margin:0;text-indent:7.1pt;margin-right:-6.3pt'><I>29.0%</I></P>
</TD><TD valign=top style=width:60.65pt><P align=center style='font:11pt Times New Roman;margin:0;text-indent:7.1pt;margin-right:-6.3pt'>22.6%</P>
<P align=center style='font:11pt Times New Roman;margin:0;text-indent:7.1pt;margin-right:-6.3pt'><I>23.8%</I></P>
</TD></TR>
</TABLE>
<P style='font:11pt Times New Roman;margin-top:6pt;margin-bottom:0pt'>Note: &nbsp;The Net Income Margin is NI, after subtracting a provision for taxes, divided by sales.</P>
<P style='font:11pt Times New Roman;margin-top:6pt;margin-bottom:0pt'>In 2020, because the Company did not make drastic cuts to its operating overheads to try to match the lower sales activity, profit margins suffered relative to UTMD&#8217;s performance in prior years, but still remained very solid in regard to UTMD&#8217;s ability to remain viable during the pandemic. The decision to not cut back was based on management&#8217;s belief that most overhead expenses represented critical resources needed to support the business as it was expected to recover, together with the comfort of UTMD&#8217;s cash reserves. &nbsp;Profit margins in 2021 have returned to levels more consistent with longer term management expectations. </P>
<P style='font:11pt Times New Roman;margin-top:6pt;margin-bottom:0pt'>UTMD&#8217;s June 30, 2021 Balance Sheet, in the absence of debt, continued to strengthen. Ending Cash and Investments were $59.5 million on June 30, 2021 compared to $51.6 million on December 31, 2020, after paying $2.1 million in cash dividends to stockholders during 1H 2021. Stockholders&#8217; Equity (SE) increased $4.5 million in the six month period from December 31, 2020 despite the fact that dividends reduce SE. &nbsp;Compared to June 30, 2020, one year earlier, cash increased $17.2 million and SE increased $12.1 million.</P>
<HR style='border:0;height:0;width:0;margin:14pt 0 0 0'><HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P style=line-height:0;margin:0></P>
<HR style='border:0;height:0;width:0;margin:14pt 0 0 0'><P style='font:11pt Times New Roman;margin-top:6pt;margin-bottom:0pt'>Foreign currency exchange (FX) rates for Balance Sheet purposes are the applicable rates at the end of each reporting period. The FX rates from the applicable foreign currency to USD for assets and liabilities at the end of 2Q 2021 compared to the end of calendar year 2020 and the end of 2Q 2020 follow:</P>
<TABLE style=border-collapse:collapse><TR><TD valign=top style=width:78.6pt><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:52.8pt><P align=right style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>6-30-21</FONT></P>
</TD><TD valign=top style=width:58.5pt><P align=right style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>12-31-20</FONT></P>
</TD><TD valign=top style='width:67.5pt;border-right:1.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>Change</FONT></P>
</TD><TD valign=top style='width:58.5pt;border-left:1.5pt solid #000000'><P align=right style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>6-30-20</FONT></P>
</TD><TD valign=top style=width:76.5pt><P align=center style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>Change</FONT></P>
</TD></TR>
<TR><TD valign=top style=width:78.6pt><P style='font:11pt Times New Roman;margin:0'>GBP</P>
</TD><TD valign=top style=width:52.8pt><P align=right style='font:11pt Times New Roman;margin:0'>1.38065</P>
</TD><TD valign=top style=width:58.5pt><P align=right style='font:11pt Times New Roman;margin:0'>1.36631</P>
</TD><TD valign=top style='width:67.5pt;border-right:1.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>1.0%</P>
</TD><TD valign=top style='width:58.5pt;border-left:1.5pt solid #000000'><P align=right style='font:11pt Times New Roman;margin:0'>1.23685</P>
</TD><TD valign=top style=width:76.5pt><P align=center style='font:11pt Times New Roman;margin:0'>11.6%</P>
</TD></TR>
<TR><TD valign=top style=width:78.6pt><P style='font:11pt Times New Roman;margin:0'>EUR</P>
</TD><TD valign=top style=width:52.8pt><P align=right style='font:11pt Times New Roman;margin:0'>1.18514</P>
</TD><TD valign=top style=width:58.5pt><P align=right style='font:11pt Times New Roman;margin:0'>1.22281</P>
</TD><TD valign=top style='width:67.5pt;border-right:1.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>(3.1%)</P>
</TD><TD valign=top style='width:58.5pt;border-left:1.5pt solid #000000'><P align=right style='font:11pt Times New Roman;margin:0'>1.12346</P>
</TD><TD valign=top style=width:76.5pt><P align=center style='font:11pt Times New Roman;margin:0'>5.5%</P>
</TD></TR>
<TR><TD valign=top style=width:78.6pt><P style='font:11pt Times New Roman;margin:0'>AUD</P>
</TD><TD valign=top style=width:52.8pt><P align=right style='font:11pt Times New Roman;margin:0'>0.74952</P>
</TD><TD valign=top style=width:58.5pt><P align=right style='font:11pt Times New Roman;margin:0'>0.77079</P>
</TD><TD valign=top style='width:67.5pt;border-right:1.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>(2.8%)</P>
</TD><TD valign=top style='width:58.5pt;border-left:1.5pt solid #000000'><P align=right style='font:11pt Times New Roman;margin:0'>0.68897</P>
</TD><TD valign=top style=width:76.5pt><P align=center style='font:11pt Times New Roman;margin:0'>8.8%</P>
</TD></TR>
<TR><TD valign=top style=width:78.6pt><P style='font:11pt Times New Roman;margin:0'>CAD</P>
</TD><TD valign=top style=width:52.8pt><P align=right style='font:11pt Times New Roman;margin:0'>0.80619</P>
</TD><TD valign=top style=width:58.5pt><P align=right style='font:11pt Times New Roman;margin:0'>0.78406</P>
</TD><TD valign=top style='width:67.5pt;border-right:1.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>2.8%</P>
</TD><TD valign=top style='width:58.5pt;border-left:1.5pt solid #000000'><P align=right style='font:11pt Times New Roman;margin:0'>0.73437</P>
</TD><TD valign=top style=width:76.5pt><P align=center style='font:11pt Times New Roman;margin:0'>9.8%</P>
</TD></TR>
</TABLE>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>Revenues (sales)</FONT> -<FONT style='border-bottom:1px solid #000000'>2Q 2021</FONT></P>
<P style='font:11pt Times New Roman;margin:0'>Total consolidated 2Q 2021 UTMD worldwide (WW) sales were $3,817 (+43.4%) higher than in 2Q 2020. Constant currency sales were $3,487 (+39.7%) higher. U.S. domestic sales were 46% higher and outside the U.S. (OUS) sales were 40% higher. Without the help of a weaker USD in converting foreign currency sales, OUS sales were 30% higher (i.e. constant currency sales). Despite the WW excellent double-digit percentage recovery in sales, 2Q U.S. domestic sales continued to improve faster than OUS sales. Because of the relatively short span of time, results for any given three month period in comparison with a previous three month period may not be indicative of comparative results for the year as a whole. </P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>Domestic U.S. sales in 2Q 2021 were $8,023 compared to $5,513 in 2Q 2020. &nbsp;Domestic sales are invoiced in USD and not subject to FX rate fluctuations. The components of domestic sales include 1) &#8220;direct other device sales&#8221; of UTMD&#8217;s medical devices to user facilities (and med/surg stocking distributors for hospitals), excluding Filshie device sales, 2) &#8220;OEM sales&#8221; of components and other products manufactured by UTMD for other medical device and non-medical device companies, and 3) &#8220;direct Filshie device sales&#8221;. UTMD separates Filshie device sales from other medical device sales direct to medical facilities because of their significance, and the acquisition history. Direct other device sales, representing 47% of total domestic sales, were $926 (+33%) higher in 2Q 2021 than in 2Q 2020. OEM sales, representing 33% of total domestic sales, were $1,126 (+72%) higher. Direct Filshie device sales, representing 20% of total domestic sales, were $457 (+40%) higher in 2Q 2021 compared to 2Q 2020. </P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>OUS sales in 2Q 2021 were 40% higher at $4,581 compared to $3,274 in 2Q 2020. The increase in USD-denominated OUS sales is overstated as a result of a weaker USD which added $329 to OUS sales that were invoiced in GBP, EUR, AUD and CAD foreign currencies (in constant currency terms). &nbsp;&#8220;Constant currency&#8221; sales means exchanging foreign currency sales into USD-denominated sales at the same FX rate as was in the previous period of time being compared. FX rates for income statement purposes are transaction-weighted averages. The average FX rates from the applicable foreign currency to USD during 2Q 2021 and 2Q 2020 for revenue purposes follow:</P>
<P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;font:11pt Times New Roman;margin-left:180pt'><FONT style='border-bottom:1px solid #000000'>2Q 2021</FONT></KBD><KBD style=margin-left:248.1pt></KBD><FONT style='border-bottom:1px solid #000000'>2Q 2020</FONT> &nbsp;&nbsp;&nbsp;<FONT style='border-bottom:1px solid #000000'>Change</FONT>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;font:11pt Times New Roman;margin-left:108pt'>GBP</KBD><KBD style='position:absolute;font:11pt Times New Roman;margin-left:180pt'> 1.3986</KBD><KBD style='position:absolute;font:11pt Times New Roman;margin-left:248.1pt'> 1.2416</KBD><KBD style=margin-left:297.7pt></KBD>+12.6%&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;font:11pt Times New Roman;margin-left:108pt'>EUR</KBD><KBD style='position:absolute;font:11pt Times New Roman;margin-left:180pt'> 1.2043</KBD><KBD style='position:absolute;font:11pt Times New Roman;margin-left:248.1pt'> 1.1100</KBD><KBD style=margin-left:297.7pt></KBD>+ &nbsp;8.5%&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;font:11pt Times New Roman;margin-left:108pt'>AUD</KBD><KBD style='position:absolute;font:11pt Times New Roman;margin-left:180pt'> 0.7696</KBD><KBD style='position:absolute;font:11pt Times New Roman;margin-left:248.1pt'> 0.6638</KBD><KBD style=margin-left:297.7pt></KBD>+15.9%&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;font:11pt Times New Roman;margin-left:108pt'>CAD</KBD><KBD style='position:absolute;font:11pt Times New Roman;margin-left:180pt'> 0.8119</KBD><KBD style='position:absolute;font:11pt Times New Roman;margin-left:248.1pt'> 0.7231</KBD><KBD style=margin-left:297.7pt></KBD>+12.3%&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>The weighted average favorable impact on 2Q 2021 foreign currency OUS sales was 10.8%, increasing reported USD sales by $329 relative to the same foreign currency sales in 2Q 2020. &nbsp;In constant currency terms, foreign currency sales in 2Q 2021 were 92.9% higher than in 2Q 2020. The portion of OUS sales invoiced in foreign currencies in USD terms were 27% of total consolidated 2Q 2021 sales compared to 18% in 2Q 2020. &nbsp;&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>OUS sales invoiced in foreign currencies are due to direct end-user sales in Ireland, the UK, France, Canada, Australia and New Zealand, and to shipments to OUS distributors of products manufactured by UTMD subsidiaries in Ireland and the UK. &nbsp;Export sales from the U.S. to OUS distributors are invoiced in USD. &nbsp;Direct to end-user OUS 2Q 2021 sales in USD terms were 101% higher in Ireland, 71% higher in Canada, 146% higher in France and 247% higher in the UK. Direct to end-user sales in Australia, which included New Zealand in 2Q 2021 but not in 2Q 2020, were 80% higher. Sales to OUS distributors were 9% higher in 2Q 2021 than in 2Q 2020. </P>
<HR style='border:0;height:0;width:0;margin:14pt 0 0 0'><HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P style=line-height:0;margin:0></P>
<HR style='border:0;height:0;width:0;margin:14pt 0 0 0'><P style='font:11pt Times New Roman;margin-top:6pt;margin-bottom:0pt'><FONT style='border-bottom:1px solid #000000'>Sales</FONT> -<FONT style='border-bottom:1px solid #000000'>1H 2021</FONT></P>
<P style='font:11pt Times New Roman;margin:0'>Total consolidated 1H 2021 UTMD worldwide (WW) sales were $3,879 (+19.7%) higher than in 1H 2020. Constant currency sales were $3,298 (+16.8%) higher. U.S. domestic sales were 24% higher and OUS sales were 13% higher. Without the help of a weaker USD in converting foreign currency sales, OUS sales were 6% higher.  </P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>Domestic U.S. sales in 1H 2021 were $14,805 compared to $11,956 in 1H 2020. &nbsp;Direct other device sales, representing 48% of total domestic sales, were $952 (+15%) higher in 1H 2021 than in 1H 2020. OEM sales, representing 31% of total domestic sales, were $1,646 (+56%) higher. Direct Filshie device sales, representing 21% of total domestic sales, were $251 (+9%) higher in 1H 2021 compared to 1H 2020. </P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>OUS sales in 1H 2021 were 13% higher at $8,762 compared to $7,733 in 1H 2020. The increase in USD-denominated 1H 2021 OUS sales is overstated as a result of a weaker USD which added $581 to OUS sales that were invoiced in GBP, EUR, AUD and CAD foreign currencies (in constant currency terms). &nbsp;FX rates for income statement purposes are transaction-weighted averages. The average FX rates from the applicable foreign currency to USD during 1H 2021 and 1H 2020 for revenue purposes follow:</P>
<P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;font:11pt Times New Roman;margin-left:180pt'><FONT style='border-bottom:1px solid #000000'>1H 2021</FONT></KBD><KBD style=margin-left:248.1pt></KBD><FONT style='border-bottom:1px solid #000000'>1H 2020</FONT> &nbsp;&nbsp;&nbsp;<FONT style='border-bottom:1px solid #000000'>Change</FONT>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;font:11pt Times New Roman;margin-left:108pt'>GBP</KBD><KBD style='position:absolute;font:11pt Times New Roman;margin-left:180pt'> 1.3908</KBD><KBD style='position:absolute;font:11pt Times New Roman;margin-left:248.1pt'> 1.2718</KBD><KBD style=margin-left:297.7pt></KBD>+ &nbsp;9.4%&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;font:11pt Times New Roman;margin-left:108pt'>EUR</KBD><KBD style='position:absolute;font:11pt Times New Roman;margin-left:180pt'> 1.2037</KBD><KBD style='position:absolute;font:11pt Times New Roman;margin-left:248.1pt'> 1.1089</KBD><KBD style=margin-left:297.7pt></KBD>+ &nbsp;8.5%&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;font:11pt Times New Roman;margin-left:108pt'>AUD</KBD><KBD style='position:absolute;font:11pt Times New Roman;margin-left:180pt'> 0.7711</KBD><KBD style='position:absolute;font:11pt Times New Roman;margin-left:248.1pt'> 0.6585</KBD><KBD style=margin-left:297.7pt></KBD>+17.1%&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;font:11pt Times New Roman;margin-left:108pt'>CAD</KBD><KBD style='position:absolute;font:11pt Times New Roman;margin-left:180pt'> 0.8009</KBD><KBD style='position:absolute;font:11pt Times New Roman;margin-left:248.1pt'> 0.7409</KBD><KBD style=margin-left:297.7pt></KBD>+ &nbsp;8.1%&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>The weighted average favorable impact on 1H 2021 foreign currency OUS sales was 10.0%, increasing reported USD sales by $581 relative to the same foreign currency sales in 1H 2020. &nbsp;In constant currency terms, OUS sales in 1H 2021 were 5.8% higher than in 1H 2020. The portion of OUS sales invoiced in foreign currencies in USD terms were 27% of total consolidated 1H 2021 sales compared to 23% in 1H 2020. Direct to end-user OUS 1H 2021 sales in USD terms were 26% higher in Ireland, 8% higher in Canada, 27% higher in France and 17% higher in the UK. &nbsp;Direct to end-user sales in Australia, which included New Zealand in 1H 2021 but not in 1H 2020, were 32% higher. Sales to OUS distributors were 9% higher in 1H 2021 than in 1H 2020. </P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>Gross Profit (GP)</FONT> </P>
<P style='font:11pt Times New Roman;margin:0'>GP results from subtracting the costs of manufacturing, quality assurance and receiving materials from suppliers. UTMD&#8217;s GP was $2,835 (+57.3%) higher in 2Q 2021 than in 2Q 2020, and $2,946 (+25.0%) higher in 1H 2021 than in 1H 2020. &nbsp;The primary contribution to an expanded GP Margin (GPM) was much greater dilution of fixed manufacturing overhead costs by 43% higher sales in 2Q 2021, and 20% higher sales in 1H 2021. The greater percentage increase in GP than in sales is due to the ability to leverage fixed costs. Incremental direct labor costs did increase as a result of competition for a limited number of people currently seeking work. Also during 2Q 2021, UTMD experienced double-digit percentage cost increases in a number of raw materials, as well as in the freight cost to receive the materials. The growing administrative burden of compliance with regulatory requirements, particularly OUS, continues to pressure UTMD&#8217;s GPM. Managing variable manufacturing costs will continue to be a significant challenge for the rest of 2021. &nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>Operating Income (OI)</FONT> </P>
<P style='font:11pt Times New Roman;margin:0'>OI results from subtracting Operating Expenses (OE) from GP. After subtracting OE from substantially higher 2Q and 1H 2021 GP, OI in 2Q 2021 was $4,765 compared to $1,977 in 2Q 2020, an increase of 141%, and was $8,652 in 1H 2021 compared to $5,840 in 1H 2020, an increase of 48%. Despite OE in USD being slightly higher in 2021 than in the same 2020 time periods, as shown in the table below, the period-to-same period increases in 2021 GP were further leveraged as a result of better OE absorption (lower percentage of sales). </P>
<HR style='border:0;height:0;width:0;margin:14pt 0 0 0'><HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P style=line-height:0;margin:0></P>
<HR style='border:0;height:0;width:0;margin:14pt 0 0 0'><P style='font:11pt Times New Roman;margin:0'>OE are comprised of Sales and Marketing (S&amp;M) expenses, General and Administrative (G&amp;A) expenses and Product Development (R&amp;D) expenses. The following table summarizes OE in 2Q and 1H 2021 compared to the same periods in 2020 by OE category:</P>
<TABLE style=border-collapse:collapse><TR><TD valign=bottom style=width:59.4pt><P style='font:11pt Times New Roman;margin:0'>OE</P>
<P style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>Category</FONT></P>
</TD><TD valign=bottom style=width:54pt><P align=center style='font:11pt Times New Roman;margin-top:6pt;margin-bottom:0pt'><FONT style='border-bottom:1px solid #000000'>2Q 2021</FONT></P>
</TD><TD valign=bottom style='width:43.8pt;border-right:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>% of</P>
<P align=center style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>sales</FONT></P>
</TD><TD valign=bottom style='width:52.4pt;border-left:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin-top:6pt;margin-bottom:0pt'><FONT style='border-bottom:1px solid #000000'>2Q 2020</FONT></P>
</TD><TD valign=bottom style='width:52.4pt;border-right:1.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin-top:6pt;margin-bottom:0pt'>% of</P>
<P align=center style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>sales</FONT></P>
</TD><TD valign=bottom style='width:52.4pt;border-left:1.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin-top:6pt;margin-bottom:0pt'><FONT style='border-bottom:1px solid #000000'>1H 2021</FONT></P>
</TD><TD valign=bottom style='width:52.4pt;border-right:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>% of</P>
<P align=center style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>sales</FONT></P>
</TD><TD valign=bottom style='width:52.4pt;border-left:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin-top:6pt;margin-bottom:0pt'><FONT style='border-bottom:1px solid #000000'>1H 2020</FONT></P>
</TD><TD valign=bottom style=width:52.4pt><P align=center style='font:11pt Times New Roman;margin-top:6pt;margin-bottom:0pt'>% of</P>
<P align=center style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>sales</FONT></P>
</TD></TR>
<TR><TD valign=top style=width:59.4pt><P style='font:11pt Times New Roman;margin:0'>S&amp;M:</P>
</TD><TD valign=top style=width:54pt><P align=center style='font:11pt Times New Roman;margin:0'>$ 364</P>
</TD><TD valign=top style='width:43.8pt;border-right:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>2.9</P>
</TD><TD valign=top style='width:52.4pt;border-left:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>$ 424</P>
</TD><TD valign=top style='width:52.4pt;border-right:1.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'> &nbsp;4.8</P>
</TD><TD valign=top style='width:52.4pt;border-left:1.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>$ 748</P>
</TD><TD valign=top style='width:52.4pt;border-right:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'> &nbsp;3.2</P>
</TD><TD valign=top style='width:52.4pt;border-left:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>$ 844</P>
</TD><TD valign=top style=width:52.4pt><P align=center style='font:11pt Times New Roman;margin:0'> &nbsp;4.3</P>
</TD></TR>
<TR><TD valign=top style=width:59.4pt><P style='font:11pt Times New Roman;margin:0'>G&amp;A:</P>
</TD><TD valign=top style=width:54pt><P align=center style='font:11pt Times New Roman;margin:0'>2,528</P>
</TD><TD valign=top style='width:43.8pt;border-right:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>20.1</P>
</TD><TD valign=top style='width:52.4pt;border-left:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>2,433</P>
</TD><TD valign=top style='width:52.4pt;border-right:1.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>27.7</P>
</TD><TD valign=top style='width:52.4pt;border-left:1.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>5,073</P>
</TD><TD valign=top style='width:52.4pt;border-right:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>21.5</P>
</TD><TD valign=top style='width:52.4pt;border-left:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>4,852</P>
</TD><TD valign=top style=width:52.4pt><P align=center style='font:11pt Times New Roman;margin:0'>24.6</P>
</TD></TR>
<TR><TD valign=top style=width:59.4pt><P style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>R&amp;D:</FONT></P>
</TD><TD valign=top style=width:54pt><P align=center style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'> &nbsp;&nbsp;128</FONT></P>
</TD><TD valign=top style='width:43.8pt;border-right:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>1.0</FONT></P>
</TD><TD valign=top style='width:52.4pt;border-left:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'> &nbsp;116</FONT></P>
</TD><TD valign=top style='width:52.4pt;border-right:1.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'> &nbsp;1.3</FONT></P>
</TD><TD valign=top style='width:52.4pt;border-left:1.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'> &nbsp;&nbsp;259</FONT></P>
</TD><TD valign=top style='width:52.4pt;border-right:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'> &nbsp;1.1</FONT></P>
</TD><TD valign=top style='width:52.4pt;border-left:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'> &nbsp;250</FONT></P>
</TD><TD valign=top style=width:52.4pt><P align=center style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'> &nbsp;1.3</FONT></P>
</TD></TR>
<TR><TD valign=top style=width:59.4pt><P style='font:11pt Times New Roman;margin:0'>Total OE:</P>
</TD><TD valign=top style=width:54pt><P align=center style='font:11pt Times New Roman;margin:0'>3,020</P>
</TD><TD valign=top style='width:43.8pt;border-right:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>24.0</P>
</TD><TD valign=top style='width:52.4pt;border-left:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>2,973</P>
</TD><TD valign=top style='width:52.4pt;border-right:1.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>33.8</P>
</TD><TD valign=top style='width:52.4pt;border-left:1.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>6,080</P>
</TD><TD valign=top style='width:52.4pt;border-right:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>25.8</P>
</TD><TD valign=top style='width:52.4pt;border-left:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>5,946</P>
</TD><TD valign=top style=width:52.4pt><P align=center style='font:11pt Times New Roman;margin:0'>30.2</P>
</TD></TR>
</TABLE>
<P style='font:11pt Times New Roman;margin-top:6pt;margin-bottom:0pt'>Although a weaker USD helped increase consolidated USD sales in 2021, it also helped increase the USD-denominated OE of UTMD&#8217;s foreign subsidiaries by $109 in 2Q 2021 and $169 in 1H 2021. The following table summarizes &#8220;constant currency&#8221; OE in 2Q and 1H 2021 compared to the same periods in 2020 by OE category:</P>
<TABLE style=border-collapse:collapse><TR><TD valign=bottom style=width:59.4pt><P style='font:11pt Times New Roman;margin-top:6pt;margin-bottom:0pt'>OE</P>
<P style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>Category</FONT></P>
</TD><TD valign=bottom style=width:54pt><P align=center style='font:11pt Times New Roman;margin-top:6pt;margin-bottom:0pt'>2Q 2021 <FONT style='border-bottom:1px solid #000000'>const FX</FONT></P>
</TD><TD valign=bottom style='width:43.8pt;border-right:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin-top:6pt;margin-bottom:0pt'>&nbsp;</P>
</TD><TD valign=bottom style='width:52.4pt;border-left:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin-top:6pt;margin-bottom:0pt'><FONT style='border-bottom:1px solid #000000'>2Q 2020</FONT></P>
</TD><TD valign=bottom style='width:52.4pt;border-right:1.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin-top:6pt;margin-bottom:0pt'>&nbsp;</P>
</TD><TD valign=bottom style='width:52.4pt;border-left:1.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin-top:6pt;margin-bottom:0pt'>1H 2021 <FONT style='border-bottom:1px solid #000000'>const FX</FONT></P>
</TD><TD valign=bottom style='width:52.4pt;border-right:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin-top:6pt;margin-bottom:0pt'>&nbsp;</P>
</TD><TD valign=bottom style='width:52.4pt;border-left:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin-top:6pt;margin-bottom:0pt'><FONT style='border-bottom:1px solid #000000'>1H 2020</FONT></P>
</TD><TD valign=top style=width:52.4pt><P align=center style='font:11pt Times New Roman;margin-top:6pt;margin-bottom:0pt'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:59.4pt><P style='font:11pt Times New Roman;margin:0'>S&amp;M:</P>
</TD><TD valign=top style=width:54pt><P align=center style='font:11pt Times New Roman;margin:0'>$ 352</P>
</TD><TD valign=top style='width:43.8pt;border-right:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style='width:52.4pt;border-left:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>$ 424</P>
</TD><TD valign=top style='width:52.4pt;border-right:1.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style='width:52.4pt;border-left:1.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>$ 729</P>
</TD><TD valign=top style='width:52.4pt;border-right:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style='width:52.4pt;border-left:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>$ 844</P>
</TD><TD valign=top style=width:52.4pt><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:59.4pt><P style='font:11pt Times New Roman;margin:0'>G&amp;A:</P>
</TD><TD valign=top style=width:54pt><P align=center style='font:11pt Times New Roman;margin:0'>2,432</P>
</TD><TD valign=top style='width:43.8pt;border-right:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style='width:52.4pt;border-left:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>2,433</P>
</TD><TD valign=top style='width:52.4pt;border-right:1.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style='width:52.4pt;border-left:1.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>4,924</P>
</TD><TD valign=top style='width:52.4pt;border-right:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style='width:52.4pt;border-left:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>4,852</P>
</TD><TD valign=top style=width:52.4pt><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:59.4pt><P style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>R&amp;D:</FONT></P>
</TD><TD valign=top style=width:54pt><P align=center style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'> &nbsp;&nbsp;127</FONT></P>
</TD><TD valign=top style='width:43.8pt;border-right:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style='width:52.4pt;border-left:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'> &nbsp;116</FONT></P>
</TD><TD valign=top style='width:52.4pt;border-right:1.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style='width:52.4pt;border-left:1.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'> &nbsp;&nbsp;258</FONT></P>
</TD><TD valign=top style='width:52.4pt;border-right:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style='width:52.4pt;border-left:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'> &nbsp;250</FONT></P>
</TD><TD valign=top style=width:52.4pt><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:59.4pt><P style='font:11pt Times New Roman;margin:0'>Total OE:</P>
</TD><TD valign=top style=width:54pt><P align=center style='font:11pt Times New Roman;margin:0'>2,911</P>
</TD><TD valign=top style='width:43.8pt;border-right:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style='width:52.4pt;border-left:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>2,973</P>
</TD><TD valign=top style='width:52.4pt;border-right:1.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style='width:52.4pt;border-left:1.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>5,911</P>
</TD><TD valign=top style='width:52.4pt;border-right:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style='width:52.4pt;border-left:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>5,946</P>
</TD><TD valign=top style=width:52.4pt><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
</TABLE>
<P style='font:11pt Times New Roman;margin-top:6pt;margin-bottom:0pt'>In other words, 2021 OE converted to USD at the same FX rate were actually lower than in 2020. Holding OE constant while dramatically increasing revenues with a higher GPM had a huge favorable impact on OI.</P>
<P style='font:11pt Times New Roman;margin-top:6pt;margin-bottom:0pt'>The change in FX rates increased 2Q 2021 OUS S&amp;M expenses by $12, and 1H 2021 OUS S&amp;M expense by $19. The lower constant currency S&amp;M expenses were due primarily to a reduction of outside sales representatives in the UK.</P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>A division of G&amp;A expenses by location follows. G&amp;A expenses include non-cash expenses from the amortization of IIA associated with the Filshie Clip System, which is also separated out below:  </P>
<TABLE style=border-collapse:collapse;width:432.9pt><TR><TD valign=bottom style=width:86.4pt><P style='font:11pt Times New Roman;margin:0'>G&amp;A Exp <FONT style='border-bottom:1px solid #000000'>Category</FONT></P>
</TD><TD valign=bottom style=width:54pt><P align=center style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>2Q 2021</FONT></P>
</TD><TD valign=bottom style='width:36pt;border-right:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>% of <FONT style='border-bottom:1px solid #000000'>sales</FONT></P>
</TD><TD valign=bottom style='width:52.4pt;border-left:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>2Q 2020</FONT></P>
</TD><TD valign=bottom style='width:33.1pt;border-right:1.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>% of <FONT style='border-bottom:1px solid #000000'>sales</FONT></P>
</TD><TD valign=bottom style='width:52.4pt;border-left:1.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>1H 2021</FONT></P>
</TD><TD valign=bottom style='width:33.1pt;border-right:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>% of <FONT style='border-bottom:1px solid #000000'>sales</FONT></P>
</TD><TD valign=bottom style='width:52.4pt;border-left:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>1H 2020</FONT></P>
</TD><TD valign=bottom style=width:33.1pt><P align=center style='font:11pt Times New Roman;margin:0'>% of <FONT style='border-bottom:1px solid #000000'>sales</FONT></P>
</TD></TR>
<TR><TD valign=top style=width:86.4pt><P style='font:11pt Times New Roman;margin:0'>IIA Amort- UK:</P>
</TD><TD valign=top style=width:54pt><P align=center style='font:11pt Times New Roman;margin:0'>$ 556</P>
</TD><TD valign=top style='width:36pt;border-right:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'> 4.4</P>
</TD><TD valign=top style='width:52.4pt;border-left:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>$ 495</P>
</TD><TD valign=top style='width:33.1pt;border-right:1.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'> &nbsp;5.6</P>
</TD><TD valign=top style='width:52.4pt;border-left:1.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>$1,106</P>
</TD><TD valign=top style='width:33.1pt;border-right:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'> &nbsp;4.7</P>
</TD><TD valign=top style='width:52.4pt;border-left:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>$1,007</P>
</TD><TD valign=top style=width:33.1pt><P align=center style='font:11pt Times New Roman;margin:0'> &nbsp;5.1</P>
</TD></TR>
<TR style=height:93.6pt><TD valign=top style=width:86.4pt><P style='font:11pt Times New Roman;margin:0'>IIA Amort&#8211; CSI:</P>
<P style='font:11pt Times New Roman;margin:0'>Other&#8211; UK:</P>
<P style='font:11pt Times New Roman;margin:0'>Other&#8211; US:</P>
<P style='font:11pt Times New Roman;margin:0'>IRE:</P>
<P style='font:11pt Times New Roman;margin:0'>AUS:</P>
<P style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>CAN:</FONT></P>
<P style='font:11pt Times New Roman;margin:0'>Total G&amp;A:</P>
</TD><TD valign=top style=width:54pt><P align=center style='font:11pt Times New Roman;margin:0'>1,105</P>
<P align=center style='font:11pt Times New Roman;margin:0'> &nbsp;&nbsp;155</P>
<P align=center style='font:11pt Times New Roman;margin:0'> &nbsp;&nbsp;552</P>
<P align=center style='font:11pt Times New Roman;margin:0'> &nbsp;&nbsp;&nbsp;77</P>
<P align=center style='font:11pt Times New Roman;margin:0'> &nbsp;&nbsp;&nbsp;42</P>
<P align=center style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'> &nbsp;&nbsp;&nbsp;41</FONT></P>
<P align=center style='font:11pt Times New Roman;margin:0'>2,528</P>
</TD><TD valign=top style='width:36pt;border-right:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'> 8.8</P>
<P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;</FONT></P>
<P align=center style='font:11pt Times New Roman;margin:0'>20.1</P>
</TD><TD valign=top style='width:52.4pt;border-left:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>1,105</P>
<P align=center style='font:11pt Times New Roman;margin:0'> &nbsp;&nbsp;149</P>
<P align=center style='font:11pt Times New Roman;margin:0'> &nbsp;&nbsp;546</P>
<P align=center style='font:11pt Times New Roman;margin:0'> &nbsp;&nbsp;&nbsp;68</P>
<P align=center style='font:11pt Times New Roman;margin:0'> &nbsp;&nbsp;&nbsp;35</P>
<P align=center style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'> &nbsp;&nbsp;&nbsp;35</FONT></P>
<P align=center style='font:11pt Times New Roman;margin:0'>2,433</P>
</TD><TD valign=top style='width:33.1pt;border-right:1.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>12.6</P>
<P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;</FONT></P>
<P align=center style='font:11pt Times New Roman;margin:0'>27.7</P>
</TD><TD valign=top style='width:52.4pt;border-left:1.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'> &nbsp;2,210</P>
<P align=center style='font:11pt Times New Roman;margin:0'> &nbsp;&nbsp;&nbsp;312</P>
<P align=center style='font:11pt Times New Roman;margin:0'> 1,113</P>
<P align=center style='font:11pt Times New Roman;margin:0'> &nbsp;&nbsp;&nbsp;161</P>
<P align=center style='font:11pt Times New Roman;margin:0'> &nbsp;&nbsp;&nbsp;&nbsp;88</P>
<P align=center style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'> &nbsp;&nbsp;&nbsp;&nbsp;83</FONT></P>
<P align=center style='font:11pt Times New Roman;margin:0'>5,073</P>
</TD><TD valign=top style='width:33.1pt;border-right:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'> &nbsp;9.4</P>
<P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</FONT></P>
<P align=center style='font:11pt Times New Roman;margin:0'>21.5</P>
</TD><TD valign=top style='width:52.4pt;border-left:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'> &nbsp;2,210</P>
<P align=center style='font:11pt Times New Roman;margin:0'> &nbsp;&nbsp;&nbsp;293</P>
<P align=center style='font:11pt Times New Roman;margin:0'> 1,054</P>
<P align=center style='font:11pt Times New Roman;margin:0'> &nbsp;&nbsp;&nbsp;126</P>
<P align=center style='font:11pt Times New Roman;margin:0'> &nbsp;&nbsp;&nbsp;&nbsp;88</P>
<P align=center style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'> &nbsp;&nbsp;&nbsp;&nbsp;73</FONT></P>
<P align=center style='font:11pt Times New Roman;margin:0'>4,852</P>
</TD><TD valign=top style=width:33.1pt><P align=center style='font:11pt Times New Roman;margin:0'>11.2</P>
<P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</FONT></P>
<P align=center style='font:11pt Times New Roman;margin:0'>24.6</P>
</TD></TR>
</TABLE>
<HR style='border:0;height:0;width:0;margin:14pt 0 0 0'><HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P style=line-height:0;margin:0></P>
<HR style='border:0;height:0;width:0;margin:14pt 0 0 0'><P style='font:11pt Times New Roman;margin:0'>About two-thirds of G&amp;A expenses in all periods above were from the non-cash expense of amortizing IIA related to the Filshie Clip System. OUS G&amp;A expenses were $871 in 2Q 2021 compared to $782 in 2Q 2020. OUS G&amp;A expenses were $1,750 in 1H 2021 compared to $1,587 in 1H 2020. &nbsp;Per the table below which identifies &#8220;constant currency&#8221; OUS G&amp;A expenses for 2Q and 1H 2021 compared to the same periods in 2020, virtually all of the increases in OUS G&amp;A expenses in both periods were due to FX rate changes:</P>
<TABLE style=border-collapse:collapse;width:432.9pt><TR style=height:19.35pt><TD valign=bottom style=width:86.4pt><P style='font:11pt Times New Roman;margin-top:6pt;margin-bottom:0pt'>G&amp;A Exp <FONT style='border-bottom:1px solid #000000'>Category</FONT></P>
</TD><TD valign=bottom style=width:54pt><P align=center style='font:11pt Times New Roman;margin:0'>2Q 2021 <FONT style='border-bottom:1px solid #000000'>const FX</FONT></P>
</TD><TD valign=bottom style=width:36pt><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:52.4pt><P align=center style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>2Q 2020</FONT></P>
</TD><TD valign=bottom style=width:33.1pt><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:52.4pt><P align=center style='font:11pt Times New Roman;margin:0'>1H 2021 <FONT style='border-bottom:1px solid #000000'>const FX</FONT></P>
</TD><TD valign=bottom style=width:33.1pt><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:52.4pt><P align=center style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>1H 2020</FONT></P>
</TD><TD valign=top style=width:33.1pt><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:86.4pt><P style='font:11pt Times New Roman;margin:0'>IIA Amort- UK:</P>
</TD><TD valign=top style=width:54pt><P align=center style='font:11pt Times New Roman;margin:0'>$ 493</P>
</TD><TD valign=top style=width:36pt><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:52.4pt><P align=center style='font:11pt Times New Roman;margin:0'>$ 495</P>
</TD><TD valign=top style=width:33.1pt><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:52.4pt><P align=center style='font:11pt Times New Roman;margin:0'>$1,014</P>
</TD><TD valign=top style=width:33.1pt><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:52.4pt><P align=center style='font:11pt Times New Roman;margin:0'>$1,007</P>
</TD><TD valign=top style=width:33.1pt><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR style=height:69.75pt><TD valign=top style=width:86.4pt><P style='font:11pt Times New Roman;margin:0'>Other&#8211; UK:</P>
<P style='font:11pt Times New Roman;margin:0'>IRE:</P>
<P style='font:11pt Times New Roman;margin:0'>AUS:</P>
<P style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>CAN:</FONT></P>
<P style='font:11pt Times New Roman;margin:0'>Total G&amp;A:</P>
</TD><TD valign=top style=width:54pt><P align=center style='font:11pt Times New Roman;margin:0'> &nbsp;&nbsp;137</P>
<P align=center style='font:11pt Times New Roman;margin:0'> &nbsp;&nbsp;&nbsp;71</P>
<P align=center style='font:11pt Times New Roman;margin:0'> &nbsp;&nbsp;&nbsp;37</P>
<P align=center style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'> &nbsp;&nbsp;&nbsp;36</FONT></P>
<P align=center style='font:11pt Times New Roman;margin:0'> &nbsp;774</P>
</TD><TD valign=top style=width:36pt><P align=center style='font:11pt Times New Roman;margin:0'> &nbsp;</P>
<P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:52.4pt><P align=center style='font:11pt Times New Roman;margin:0'> &nbsp;&nbsp;149</P>
<P align=center style='font:11pt Times New Roman;margin:0'> &nbsp;&nbsp;&nbsp;68</P>
<P align=center style='font:11pt Times New Roman;margin:0'> &nbsp;&nbsp;&nbsp;35</P>
<P align=center style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'> &nbsp;&nbsp;&nbsp;35</FONT></P>
<P align=center style='font:11pt Times New Roman;margin:0'> &nbsp;782</P>
</TD><TD valign=top style=width:33.1pt><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:52.4pt><P align=center style='font:11pt Times New Roman;margin:0'> &nbsp;&nbsp;&nbsp;&nbsp;285</P>
<P align=center style='font:11pt Times New Roman;margin:0'> &nbsp;&nbsp;&nbsp;&nbsp;149</P>
<P align=center style='font:11pt Times New Roman;margin:0'> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;75</P>
<P align=center style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'> &nbsp;&nbsp;&nbsp;&nbsp; 77</FONT></P>
<P align=center style='font:11pt Times New Roman;margin:0'> 1,600</P>
</TD><TD valign=top style=width:33.1pt><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:52.4pt><P align=center style='font:11pt Times New Roman;margin:0'> &nbsp;&nbsp;&nbsp;293</P>
<P align=center style='font:11pt Times New Roman;margin:0'> &nbsp;&nbsp;&nbsp;126</P>
<P align=center style='font:11pt Times New Roman;margin:0'> &nbsp;&nbsp;&nbsp;&nbsp;88</P>
<P align=center style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'> &nbsp;&nbsp;&nbsp;&nbsp;73</FONT></P>
<P align=center style='font:11pt Times New Roman;margin:0'>1,587</P>
</TD><TD valign=top style=width:33.1pt><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
</TABLE>
<P style='font:11pt Times New Roman;margin:0'>Period to period product development (R&amp;D) expenses varied slightly depending on specific project costs. Since almost all R&amp;D is being carried out in the U.S., there was negligible FX rate impact. &nbsp; </P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>Income Before Tax (EBT)</FONT> </P>
<P style='font:11pt Times New Roman;margin-top:0pt;margin-bottom:6pt'>EBT results from subtracting net non-operating expense (NOE) or adding net non-operating income (NOI) from or to, as applicable, OI. &nbsp;Consolidated 2Q 2021 EBT was $4,825 (38.3% of sales) compared to $1,977 (22.5% of sales) in 2Q 2020. Consolidated 1H 2021 EBT was $8,723 (37.0% of sales) compared to $5,965 (30.3% of sales) in 1H 2020.  &nbsp;&nbsp;&nbsp;&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>NOE/NOI includes the combination of 1) expenses from loan interest and bank fees; 2) expenses or income from losses or gains from remeasuring the value of EUR cash bank balances in the UK, and GBP cash balances in Ireland, in USD terms; and 3) income from rent of underutilized property, investment income and royalties received from licensing the Company&#8217;s technology. Negative NOE is NOI. &nbsp;Net NOI in 2Q 2021 was $60 compared to essentially zero NOI in 2Q 2020. Net NOI in 1H 2021 was $71 compared to $125 NOI in 1H 2020. &nbsp;Despite higher cash balances in 2021 compared to 2020, UTMD received less in interest income. In addition, instead of a gain of $42 at the end of 1H 2020 from remeasurement of foreign currency bank balances, UTMD realized a $5 loss at the end of 1H 2021.   &nbsp;</P>
<P style='font:11pt Times New Roman;margin-top:6pt;margin-bottom:0pt'>EBITDA is a non-US GAAP metric that measures profitability performance without factoring in effects of financing, accounting decisions regarding non-cash expenses, capital expenditures or tax environments. Excluding the noncash effects of depreciation, amortization of intangible assets and stock option expense, 2Q 2021 consolidated EBT excluding the remeasured bank balance currency gain or loss and interest expense (&#8220;adjusted consolidated EBITDA&#8221;) was $6,695 compared to $3,800 in 2Q 2020. &nbsp;Adjusted consolidated EBITDA was $12,471 in 1H 2021 compared to $9,572 in 1H 2020. Adjusted consolidated EBITDA for the previous four calendar quarters (TTM) was $24,024 as of June 30, 2021. &nbsp;Based on the better than expected 2Q 2021 operating results, management expects that adjusted consolidated EBITDA of $25 million is likely achievable for the full year 2021. UTMD&#8217;s adjusted consolidated EBITDA as a percentage of sales was 53.1% in 2Q 2021 compared to 43.2% in 2Q 2020. &nbsp;UTMD&#8217;s adjusted consolidated EBITDA as a percentage of sales was 52.9% in 1H 2021 compared to 48.6% in 1H 2020. Achieving substantially higher revenues with an expanded GPM while keeping operating expenses about the same obviously had a very positive effect on this key profitability metric. &nbsp;Management believes that this operating performance metric provides meaningful supplemental information to both management and investors and confirms UTMD&#8217;s ongoing excellent financial operating performance, as well as its substantial recovery from 2020. </P>
<HR style='border:0;height:0;width:0;margin:14pt 0 0 0'><HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P style=line-height:0;margin:0></P>
<HR style='border:0;height:0;width:0;margin:14pt 0 0 0'><P style='font:11pt Times New Roman;margin-top:6pt;margin-bottom:0pt'>UTMD&#8217;s non-US GAAP adjusted consolidated EBITDA is the sum of the elements in the following table, each element of which is a US GAAP number: &nbsp;</P>
<TABLE style=border-collapse:collapse;width:432pt;margin-left:5.4pt><TR><TD valign=top style=width:207pt><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:49.5pt><P align=right style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>2Q 2021</FONT></P>
</TD><TD valign=top style='width:58.5pt;border-right:0.5pt solid #000000'><P align=right style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>2Q 2020</FONT></P>
</TD><TD valign=top style='width:58.5pt;border-left:0.5pt solid #000000'><P align=right style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>1H 2021</FONT></P>
</TD><TD valign=top style=width:58.5pt><P align=right style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>1H 2020</FONT></P>
</TD></TR>
<TR><TD valign=top style=width:207pt><P style='font:11pt Times New Roman;margin:0'>EBT</P>
</TD><TD valign=top style=width:49.5pt><P align=right style='font:11pt Times New Roman;margin:0'>$4,825</P>
</TD><TD valign=top style='width:58.5pt;border-right:0.5pt solid #000000'><P align=right style='font:11pt Times New Roman;margin:0'>$1,977</P>
</TD><TD valign=top style='width:58.5pt;border-left:0.5pt solid #000000'><P align=right style='font:11pt Times New Roman;margin:0'>$8,723</P>
</TD><TD valign=top style=width:58.5pt><P align=right style='font:11pt Times New Roman;margin:0'>$5,965</P>
</TD></TR>
<TR><TD valign=top style=width:207pt><P style='font:11pt Times New Roman;margin:0'>Depreciation Expense</P>
</TD><TD valign=top style=width:49.5pt><P align=right style='font:11pt Times New Roman;margin:0'>162</P>
</TD><TD valign=top style='width:58.5pt;border-right:0.5pt solid #000000'><P align=right style='font:11pt Times New Roman;margin:0'>161</P>
</TD><TD valign=top style='width:58.5pt;border-left:0.5pt solid #000000'><P align=right style='font:11pt Times New Roman;margin:0'>326</P>
</TD><TD valign=top style=width:58.5pt><P align=right style='font:11pt Times New Roman;margin:0'>335</P>
</TD></TR>
<TR><TD valign=top style=width:207pt><P style='font:11pt Times New Roman;margin:0'>Femcare IIA Amortization Expense</P>
</TD><TD valign=top style=width:49.5pt><P align=right style='font:11pt Times New Roman;margin:0'>556</P>
</TD><TD valign=top style='width:58.5pt;border-right:0.5pt solid #000000'><P align=right style='font:11pt Times New Roman;margin:0'>495</P>
</TD><TD valign=top style='width:58.5pt;border-left:0.5pt solid #000000'><P align=right style='font:11pt Times New Roman;margin:0'>1,106</P>
</TD><TD valign=top style=width:58.5pt><P align=right style='font:11pt Times New Roman;margin:0'>1,007</P>
</TD></TR>
<TR><TD valign=top style=width:207pt><P style='font:11pt Times New Roman;margin:0'>CSI IIA Amortization Expense</P>
</TD><TD valign=top style=width:49.5pt><P align=right style='font:11pt Times New Roman;margin:0'>1,105</P>
</TD><TD valign=top style='width:58.5pt;border-right:0.5pt solid #000000'><P align=right style='font:11pt Times New Roman;margin:0'>1,105</P>
</TD><TD valign=top style='width:58.5pt;border-left:0.5pt solid #000000'><P align=right style='font:11pt Times New Roman;margin:0'>2,211</P>
</TD><TD valign=top style=width:58.5pt><P align=right style='font:11pt Times New Roman;margin:0'>2,211</P>
</TD></TR>
<TR><TD valign=top style=width:207pt><P style='font:11pt Times New Roman;margin:0'>Other Non-Cash Amortization Expense</P>
</TD><TD valign=top style=width:49.5pt><P align=right style='font:11pt Times New Roman;margin:0'>10</P>
</TD><TD valign=top style='width:58.5pt;border-right:0.5pt solid #000000'><P align=right style='font:11pt Times New Roman;margin:0'>12</P>
</TD><TD valign=top style='width:58.5pt;border-left:0.5pt solid #000000'><P align=right style='font:11pt Times New Roman;margin:0'>18</P>
</TD><TD valign=top style=width:58.5pt><P align=right style='font:11pt Times New Roman;margin:0'>24</P>
</TD></TR>
<TR><TD valign=top style=width:207pt><P style='font:11pt Times New Roman;margin:0'>Stock Option Compensation Expense</P>
<P style='font:11pt Times New Roman;margin:0'>Interest Expense</P>
</TD><TD valign=top style=width:49.5pt><P align=right style='font:11pt Times New Roman;margin:0'>41</P>
<P align=right style='font:11pt Times New Roman;margin:0'>- </P>
</TD><TD valign=top style='width:58.5pt;border-right:0.5pt solid #000000'><P align=right style='font:11pt Times New Roman;margin:0'>49</P>
<P align=right style='font:11pt Times New Roman;margin:0'>-</P>
</TD><TD valign=top style='width:58.5pt;border-left:0.5pt solid #000000'><P align=right style='font:11pt Times New Roman;margin:0'>82</P>
<P align=right style='font:11pt Times New Roman;margin:0'>- </P>
</TD><TD valign=top style=width:58.5pt><P align=right style='font:11pt Times New Roman;margin:0'>72</P>
<P align=right style='font:11pt Times New Roman;margin:0'>-</P>
</TD></TR>
<TR><TD valign=top style='width:207pt;border-bottom:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'>Remeasured Foreign Currency Balances</P>
</TD><TD valign=top style='width:49.5pt;border-bottom:0.5pt solid #000000'><P align=right style='font:11pt Times New Roman;margin:0'>(4)</P>
</TD><TD valign=top style='width:58.5pt;border-bottom:0.5pt solid #000000;border-right:0.5pt solid #000000'><P align=right style='font:11pt Times New Roman;margin:0'>1</P>
</TD><TD valign=top style='width:58.5pt;border-left:0.5pt solid #000000;border-bottom:0.5pt solid #000000'><P align=right style='font:11pt Times New Roman;margin:0'>5</P>
</TD><TD valign=top style='width:58.5pt;border-bottom:0.5pt solid #000000'><P align=right style='font:11pt Times New Roman;margin:0'>(42)</P>
</TD></TR>
<TR><TD valign=top style='width:207pt;border-top:0.5pt solid #000000'><P align=right style='font:11pt Times New Roman;margin:0'>UTMD non-US GAAP EBITDA:</P>
</TD><TD valign=top style='width:49.5pt;border-top:0.5pt solid #000000'><P align=right style='font:11pt Times New Roman;margin:0'>$6,695</P>
</TD><TD valign=top style='width:58.5pt;border-top:0.5pt solid #000000;border-right:0.5pt solid #000000'><P align=right style='font:11pt Times New Roman;margin:0'>$3,800</P>
</TD><TD valign=top style='width:58.5pt;border-top:0.5pt solid #000000;border-left:0.5pt solid #000000'><P align=right style='font:11pt Times New Roman;margin:0'>$12,471</P>
</TD><TD valign=top style='width:58.5pt;border-top:0.5pt solid #000000'><P align=right style='font:11pt Times New Roman;margin:0'>$9,572</P>
</TD></TR>
</TABLE>
<P style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>Note</FONT></P>
<P style='font:11pt Times New Roman;margin:0'>All UTMD income statement measures from GP through EBT (and including non-US GAAP adjusted consolidated EBITDA above) for both 2021 and 2020 time periods were unaffected by the enacted changes in the UK corporate income rate.</P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>Net Income (NI)</FONT> </P>
<P style='font:11pt Times New Roman;margin:0'>US GAAP NI in 2Q 2021 of $3,426 (27.2% of sales) was 161.0% higher than the US GAAP NI of $1,313 (14.9% of sales) in 2Q 2020. Obviously, 2Q 2020 was the low point for UTMD during the COVID-19 pandemic. NI in both periods was affected by an additional tax provision expense required to be recorded in the quarter in which a tax change is enacted, as a result of an adjustment to UTMD&#8217;s deferred tax liability (DTL). &nbsp;The DTL results from the tax effect of not being able to deduct the remaining future amortization expense of Femcare IIA. &nbsp;In 2Q 2020, because the UK reset its corporate tax rate from 17% to 19% going forward, it caused UTMD to have to book an additional $225 in income taxes that represented the additional tax which would be paid in the UK over the remaining six year life of the 2011 Femcare acquisition IIA, based on a 19% rate. In 2Q 2021, because the UK reset its corporate tax rate from 19% to 25% beginning with 2Q 2023, it caused UTMD to have to book an additional $390 in its 2Q 2021 income tax provision that represents the additional tax which will be paid in the UK over the now remaining five year life of the 2011 Femcare acquisition IIA. Excluding the $390 DTL increase in 2Q 2021 and the $225 DTL increase in 2Q 2020, both of which reduced NI by those same amounts, non-US GAAP 2Q 2021 NI was $3,817 (30.3% of sales), 148.3% higher than non-US GAAP 2Q 2020 NI of $1,537 (17.5% of sales). Excluding the tax provision increases due to the DTL adjustment, non-US GAAP 1H 2021 NI was $6,840 (29.0% of sales), 46.3% higher than non-US GAAP 1H 2020 NI of $4,677 (23.8% of sales).</P>
<P style='font:11pt Times New Roman;margin-top:6pt;margin-bottom:0pt'>The average consolidated income tax provisions (as a % of the same period EBT) per US GAAP in 2Q 2021 and 2Q 2020 were 29.0% and 33.6% respectively, and were 26.1% and 25.4% in 1H 2021 and 1H 2020 respectively. As these tax rates for both 2021 and 2020 periods are not directly related to EBT generated in the same periods, UTMD provides the following tax rates excluding the 2Q 2021 $390 tax provision adjustment and the 2Q 2020 $225 income tax provision adjustment: &nbsp;The resulting non-GAAP income tax provision rates were 20.9% and 22.2% for 2Q 2021 and 2Q 2020 respectively, and were 21.6% for both 1H 2021 and 1H 2020. </P>
<P style='font:11pt Times New Roman;margin-top:6pt;margin-bottom:0pt'>The consolidated income tax provision rate varies as the mix in taxable income among U.S. and foreign subsidiaries with differing income tax rates differs from period to period. The basic corporate income tax rates in each of the sovereignties were the same as in the prior year. </P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>Earnings per share (EPS)</FONT>. &nbsp;</P>
<P style='font:11pt Times New Roman;margin-top:6pt;margin-bottom:0pt'>US GAAP diluted EPS in 2Q 2021 were $0.937 compared to $0.359 in 2Q 2020, a 161.3% increase. &nbsp;US GAAP diluted EPS in 1H 2021 were $1.765 compared to $1.207 in 1H 2020, a 46.2% increase. &nbsp;Excluding the &#8220;one-time&#8221; income tax provision increases due to the DTL adjustments, non-US GAAP diluted EPS in 2Q 2021 were $1.044 compared to $0.420 in 2Q 2020, a 148.5% increase, and non-US GAAP diluted EPS in 1H 2021 were $1.871 compared to $1.268 in 1H 2020, a 47.6% increase. In either </P>
<HR style='border:0;height:0;width:0;margin:14pt 0 0 0'><HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P style=line-height:0;margin:0></P>
<HR style='border:0;height:0;width:0;margin:14pt 0 0 0'><P style='font:11pt Times New Roman;margin-top:6pt;margin-bottom:0pt'><FONT style=font-size:11pt>case, the increases in EPS were substantial as a result of the improvement in operating results. Diluted shares were 3,655,319 in 2Q 2021 compared to 3,658,626 in 2Q 2020. &nbsp;The lower diluted shares in 2Q 2021 were the result of shares repurchased during 2020 offset by employee options exercised, and a lower dilution factor for unexercised options. </FONT></P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>The number of shares used for calculating EPS was higher than ending shares because of a time-weighted calculation of average outstanding shares plus dilution from unexercised employee and director options. Outstanding shares at the end of 2Q 2021 were 3,645,798 compared to 3,643,035 at the end of calendar year 2020. The difference was due to 2,763 shares in employee option exercises during 1H 2021. For comparison, outstanding shares were 3,642,946 at the end of 2Q 2020. The total number of outstanding unexercised employee and outside director options at June 30, 2021 was 63,874 at an average exercise price of $68.38, including shares awarded but not yet vested. &nbsp;This compares to 76,625 unexercised option shares at the end of 2Q 2020 at an average exercise price of $64.72/ share, including shares awarded but not vested. </P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>The number of shares added as a dilution factor in 2Q 2021 was 9,526 compared to 16,040 in 2Q 2020. The number of shares added as a dilution factor in 1H 2021 was 10,569 compared to 15,342 in 1H 2020. In March 2020, 26,300 option shares were awarded to 48 employees at an exercise price of $77.05 per share. No options have been awarded to date in 2021. &nbsp;UTMD paid $1,039 ($0.285/share) in dividends to stockholders in 2Q 2021 compared to $1,035 ($0.280/ share) paid in 2Q 2020. Dividends paid to stockholders during 2Q 2021 were 27% of non-US GAAP NI. UTMD paid $2,077 ($0.285/share) in dividends to stockholders in 1H 2021 compared to $2,077 ($0.280/ share) paid in 1H 2020. The increase in the per share dividend was offset by share repurchases. Dividends paid to stockholders during 1H 2021 were 30% of non-US GAAP NI. &nbsp;&nbsp;&nbsp;</P>
<P style='font:11pt Times New Roman;margin-top:6pt;margin-bottom:0pt'>In March 2020, UTMD repurchased 80,000 of its shares in the open market at $80.32/ share. In September 2020, UTMD repurchased 7,000 shares at $78.67/ share. &nbsp;No shares have been repurchased to date in 2021. The Company retains the strong desire and financial ability for repurchasing its shares at a price it believes is attractive for remaining stockholders. UTMD&#8217;s closing share price at the end of 2Q 2021 was $85.04, down from the closing price of $86.60 at the end of 1Q 2021 despite an increase in cash of $.95/ outstanding share and an increase in stockholders&#8217; equity of $.68/ share during the quarter. &nbsp;The 2Q 2021 ending share price was up less than 1% from the $84.30 closing price at the end of 2020. The closing share price at the end of the awful (for UTMD) 2Q 2020 was $88.62. </P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>Balance Sheet</FONT>.</P>
<P style='font:11pt Times New Roman;margin:0'>At June 30, 2021 compared to the end of 2020, UTMD&#8217;s cash and investments increased $7.9 million to $59.5 million primarily as a result of operating EBITDA less a $2.1 million payment of cash dividends to stockholders, plus some changes in working capital including increases in both accounts receivable from the higher sales activity and current liabilities from higher production activity. At June 30, 2021, net Intangible Assets decreased to 30.0% of total consolidated assets from 34.1% on December 31, 2020 despite a weaker USD which raises the USD value of Femcare&#8217;s GBP IIA. &nbsp;UTMD&#8217;s 15.9 current ratio at June 30, 2021 was close to the 16.4 current ratio at December 31, 2020 despite 17% higher current liabilities due to higher accrued income taxes and higher accounts payable. The average age of trade receivables was 33 days from date of invoice at June 30, 2021 compared to 31 days at December 31, 2020. &nbsp;Average inventory turns improved to 3.0 in 2Q 2021 compared to 2.5 for the 2020 year.</P>
<P style='font:11pt Times New Roman;margin-top:6pt;margin-bottom:0pt'>Financial ratios as of June 30, 2021 which may be of interest to stockholders follow:</P>
<P style='font:11pt Times New Roman;margin:0;margin-left:18pt'><KBD style='position:absolute;font:11pt Times New Roman;margin-left:-18pt'>1)</KBD>Current Ratio = 15.9&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0;margin-left:18pt'><KBD style='position:absolute;font:11pt Times New Roman;margin-left:-18pt'>2)</KBD>Days in Trade Receivables (based on 2Q 2021 sales activity) = 33&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0;margin-left:18pt'><KBD style='position:absolute;font:11pt Times New Roman;margin-left:-18pt'>3)</KBD>Average Inventory Turns (based on 2Q 2021 CGS) = 3.0&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0;margin-left:18pt'><KBD style='position:absolute;font:11pt Times New Roman;margin-left:-18pt'>4)</KBD>2021 YTD ROE (before dividends) = 13%&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>Investors are cautioned that this press release contains forward looking statements and that actual events may differ from those projected. &nbsp;Risk factors that could cause results to differ materially from those projected include global economic conditions, market acceptance of products, regulatory approvals of </P>
<HR style='border:0;height:0;width:0;margin:14pt 0 0 0'><HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P style=line-height:0;margin:0></P>
<HR style='border:0;height:0;width:0;margin:14pt 0 0 0'><P style='font:11pt Times New Roman;margin:0'><FONT style=font-size:11pt>products, regulatory intervention in current operations, government intervention in healthcare in general, tax reforms, the Company&#8217;s ability to efficiently manufacture, market and sell products, cybersecurity and foreign currency exchange rates, among other factors that have been and will be outlined in UTMD&#8217;s public disclosure filings with the SEC.</FONT></P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>Utah Medical Products, Inc., with particular interest in health care for women and their babies, develops, manufactures and markets a broad range of disposable and reusable specialty medical devices recognized by clinicians in over one hundred countries around the world as the standard for obtaining optimal long term outcomes for their patients. &nbsp;For more information about Utah Medical Products, Inc., visit UTMD&#8217;s website at<B><I> </I></B><FONT style='color:#0000FF;border-bottom:1px solid #0000FF'><I>www.utahmed.com</I></FONT>.</P>
<HR style='border:0;height:0;width:0;margin:14pt 0 0 0'><HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P style=line-height:0;margin:0></P>
<HR style='border:0;height:0;width:0;margin:14pt 0 0 0'><P align=center style='font:11pt Times New Roman;margin:0'><FONT style=font-size:13pt><B>Utah Medical Products, Inc.</B></FONT></P>
<P style='font:10pt Times New Roman;margin:0'>INCOME STATEMENT, Second Quarter (three months ended June 30)</P>
<P style='font:10pt Times New Roman;margin:0'>(in thousands except earnings per share):</P>
<TABLE style=border-collapse:collapse;width:508.2pt><TR><TD valign=top style=width:140.4pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:67.5pt><P align=right style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>2Q 2021</FONT></P>
</TD><TD valign=top style=width:70.35pt><P align=right style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>2Q 2020</FONT></P>
</TD><TD valign=top style=width:73.65pt><P align=right style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>Percent Change</FONT></P>
</TD><TD valign=top style=width:78.15pt><P align=right style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>2Q 2019</FONT></P>
</TD><TD valign=top style=width:78.15pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:140.4pt><P style='font:10pt Times New Roman;margin:0'>Net Sales</P>
</TD><TD valign=top style=width:67.5pt><P align=right style='font:10pt Times New Roman;margin:0'>$ 12,604</P>
</TD><TD valign=top style=width:70.35pt><P align=right style='font:10pt Times New Roman;margin:0'>$ 8,787</P>
</TD><TD valign=top style=width:73.65pt><P align=center style='font:10pt Times New Roman;margin:0'>43.4%</P>
</TD><TD valign=top style=width:78.15pt><P align=right style='font:10pt Times New Roman;margin:0'>$ 11,846</P>
</TD><TD valign=top style=width:78.15pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:140.4pt><P style='font:10pt Times New Roman;margin:0'>Gross Profit</P>
</TD><TD valign=top style=width:67.5pt><P align=right style='font:10pt Times New Roman;margin:0'>7,785</P>
</TD><TD valign=top style=width:70.35pt><P align=right style='font:10pt Times New Roman;margin:0'>4,950</P>
</TD><TD valign=top style=width:73.65pt><P align=center style='font:10pt Times New Roman;margin:0'>57.3%</P>
</TD><TD valign=top style=width:78.15pt><P align=right style='font:10pt Times New Roman;margin:0'>7,500</P>
</TD><TD valign=top style=width:78.15pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:140.4pt><P style='font:10pt Times New Roman;margin:0'>Operating Income</P>
</TD><TD valign=top style=width:67.5pt><P align=right style='font:10pt Times New Roman;margin:0'>4,765</P>
</TD><TD valign=top style=width:70.35pt><P align=right style='font:10pt Times New Roman;margin:0'>1,977</P>
</TD><TD valign=top style=width:73.65pt><P align=center style='font:10pt Times New Roman;margin:0'>141.0%</P>
</TD><TD valign=top style=width:78.15pt><P align=right style='font:10pt Times New Roman;margin:0'>4,481</P>
</TD><TD valign=top style=width:78.15pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style='width:140.4pt;border-bottom:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'>Income Before Tax</P>
</TD><TD valign=top style='width:67.5pt;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>4,825</P>
</TD><TD valign=top style='width:70.35pt;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>1,977</P>
</TD><TD valign=top style='width:73.65pt;border-bottom:0.5pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'>144.0%</P>
</TD><TD valign=top style='width:78.15pt;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>4,565</P>
</TD><TD valign=top style='width:78.15pt;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style='width:140.4pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><I>Net Income before DTL adjust</I></P>
<P style='font:10pt Times New Roman;margin:0'>Net Income (US GAAP)</P>
</TD><TD valign=top style='width:67.5pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'><I>3,817</I></P>
<P align=right style='font:10pt Times New Roman;margin:0'>3,426</P>
</TD><TD valign=top style='width:70.35pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'><I>1,537</I></P>
<P align=right style='font:10pt Times New Roman;margin:0'>1,313</P>
</TD><TD valign=top style='width:73.65pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'><I>148.3%</I></P>
<P align=center style='font:10pt Times New Roman;margin:0'>161.0%</P>
</TD><TD valign=top style='width:78.15pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'><I>3,525</I></P>
<P align=right style='font:10pt Times New Roman;margin:0'>3,525</P>
</TD><TD valign=top style='width:78.15pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style='width:140.4pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><I>EPS before DTL adjustment</I></P>
<P style='font:10pt Times New Roman;margin:0'>Earnings Per Share (US GAAP)</P>
</TD><TD valign=top style='width:67.5pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'><I>$1.044</I></P>
<P align=right style='font:10pt Times New Roman;margin:0'>$ .937</P>
</TD><TD valign=top style='width:70.35pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'><I>$ .420</I></P>
<P align=right style='font:10pt Times New Roman;margin:0'>$ .359</P>
</TD><TD valign=top style='width:73.65pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'><I>148.5%</I></P>
<P align=center style='font:10pt Times New Roman;margin:0'>161.3%</P>
</TD><TD valign=top style='width:78.15pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'><I>$ .944</I></P>
<P align=right style='font:10pt Times New Roman;margin:0'>$ .944</P>
</TD><TD valign=top style='width:78.15pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style='width:140.4pt;border-top:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'>Shares Outstanding (diluted)</P>
</TD><TD valign=top style='width:67.5pt;border-top:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>3,655</P>
</TD><TD valign=top style='width:70.35pt;border-top:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>3,659</P>
</TD><TD valign=top style='width:73.65pt;border-top:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style='width:78.15pt;border-top:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>3,735</P>
</TD><TD valign=top style='width:78.15pt;border-top:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
</TABLE>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>INCOME STATEMENT, First Half (six months ended June 30)</P>
<P style='font:10pt Times New Roman;margin:0'>(in thousands except earnings per share): </P>
<TABLE style=border-collapse:collapse;width:509.4pt><TR><TD valign=top style=width:134.55pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:73.35pt><P align=right style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>1H 2021</FONT></P>
</TD><TD valign=top style=width:72pt><P align=right style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>1H 2020</FONT></P>
</TD><TD valign=top style=width:76.5pt><P align=right style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>Percent Change</FONT></P>
</TD><TD valign=top style=width:76.5pt><P align=right style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>1H 2019</FONT></P>
</TD><TD valign=top style=width:76.5pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:134.55pt><P style='font:10pt Times New Roman;margin:0'>Net Sales</P>
</TD><TD valign=top style=width:73.35pt><P align=right style='font:10pt Times New Roman;margin:0'>$ 23,568</P>
</TD><TD valign=top style=width:72pt><P align=right style='font:10pt Times New Roman;margin:0'>$ 19,689</P>
</TD><TD valign=top style=width:76.5pt><P align=center style='font:10pt Times New Roman;margin:0'>19.7%</P>
</TD><TD valign=top style=width:76.5pt><P align=right style='font:10pt Times New Roman;margin:0'>$ 22,579</P>
</TD><TD valign=top style=width:76.5pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:134.55pt><P style='font:10pt Times New Roman;margin:0'>Gross Profit</P>
</TD><TD valign=top style=width:73.35pt><P align=right style='font:10pt Times New Roman;margin:0'>14,732</P>
</TD><TD valign=top style=width:72pt><P align=right style='font:10pt Times New Roman;margin:0'>11,786</P>
</TD><TD valign=top style=width:76.5pt><P align=center style='font:10pt Times New Roman;margin:0'>25.0%</P>
</TD><TD valign=top style=width:76.5pt><P align=right style='font:10pt Times New Roman;margin:0'>14,273</P>
</TD><TD valign=top style=width:76.5pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:134.55pt><P style='font:10pt Times New Roman;margin:0'>Operating Income</P>
</TD><TD valign=top style=width:73.35pt><P align=right style='font:10pt Times New Roman;margin:0'>8,652</P>
</TD><TD valign=top style=width:72pt><P align=right style='font:10pt Times New Roman;margin:0'>5,840</P>
</TD><TD valign=top style=width:76.5pt><P align=center style='font:10pt Times New Roman;margin:0'>48.2%</P>
</TD><TD valign=top style=width:76.5pt><P align=right style='font:10pt Times New Roman;margin:0'>8,582</P>
</TD><TD valign=top style=width:76.5pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style='width:134.55pt;border-bottom:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'>Income Before Tax</P>
</TD><TD valign=top style='width:73.35pt;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>8,723</P>
</TD><TD valign=top style='width:72pt;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>5,965</P>
</TD><TD valign=top style='width:76.5pt;border-bottom:0.5pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'>46.2%</P>
</TD><TD valign=top style='width:76.5pt;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>8,702</P>
</TD><TD valign=top style='width:76.5pt;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style='width:134.55pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><I>Net Income before DTL adjust</I></P>
<P style='font:10pt Times New Roman;margin:0'>Net Income (US GAAP)</P>
</TD><TD valign=top style='width:73.35pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'><I>6,840</I></P>
<P align=right style='font:10pt Times New Roman;margin:0'>6,450</P>
</TD><TD valign=top style='width:72pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'><I>4,677</I></P>
<P align=right style='font:10pt Times New Roman;margin:0'>4,452</P>
</TD><TD valign=top style='width:76.5pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'><I>46.3%</I></P>
<P align=center style='font:10pt Times New Roman;margin:0'>44.9%</P>
</TD><TD valign=top style='width:76.5pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'><I>6,664</I></P>
<P align=right style='font:10pt Times New Roman;margin:0'>6,664</P>
</TD><TD valign=top style='width:76.5pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style='width:134.55pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><I>EPS before DTL adjustment</I></P>
<P style='font:10pt Times New Roman;margin:0'>EPS (US GAAP)</P>
</TD><TD valign=top style='width:73.35pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'><I>$ 1.871</I></P>
<P align=right style='font:10pt Times New Roman;margin:0'>$ 1.765</P>
</TD><TD valign=top style='width:72pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'><I>$ 1.268</I></P>
<P align=right style='font:10pt Times New Roman;margin:0'>$ 1.207</P>
</TD><TD valign=top style='width:76.5pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'><I>47.6%</I></P>
<P align=center style='font:10pt Times New Roman;margin:0'>46.2%</P>
</TD><TD valign=top style='width:76.5pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'><I>$ 1.783</I></P>
<P align=right style='font:10pt Times New Roman;margin:0'>$ 1.783</P>
</TD><TD valign=top style='width:76.5pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style='width:134.55pt;border-top:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'>Shares Outstanding (diluted)</P>
</TD><TD valign=top style='width:73.35pt;border-top:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>3,656</P>
</TD><TD valign=top style='width:72pt;border-top:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>3,690</P>
</TD><TD valign=top style='width:76.5pt;border-top:0.5pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style='width:76.5pt;border-top:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>3,737</P>
</TD><TD valign=top style='width:76.5pt;border-top:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
</TABLE>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>BALANCE SHEET</P>
<TABLE style=border-collapse:collapse><TR style=height:21.6pt><TD valign=top style=width:203.85pt><P style='font:10pt Times New Roman;margin:0'>(in thousands)</P>
</TD><TD valign=top style=width:68.8pt><P align=right style='font:10pt Times New Roman;margin:0'>(unaudited) &nbsp;</P>
<P align=right style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>JUN 30, 2021</FONT></P>
</TD><TD valign=top style=width:72.95pt><P align=right style='font:10pt Times New Roman;margin:0'>(unaudited) &nbsp;</P>
<P align=right style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>MAR 31, 2021</FONT></P>
</TD><TD valign=top style=width:70.9pt><P align=right style='font:10pt Times New Roman;margin:0'>(audited)</P>
<P align=right style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>DEC 31, 2020</FONT></P>
</TD><TD valign=top style=width:70.85pt><P align=right style='font:10pt Times New Roman;margin:0'>(unaudited)</P>
<P align=right style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>JUN 30, 2020</FONT></P>
</TD></TR>
<TR><TD valign=top style=width:203.85pt><P style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>Assets</FONT></P>
</TD><TD valign=top style=width:68.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:72.95pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:70.9pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:70.85pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:203.85pt><P style='font:10pt Times New Roman;margin:0'> &nbsp;&nbsp;Cash &amp; Investments</P>
</TD><TD valign=top style=width:68.8pt><P align=right style='font:10pt Times New Roman;margin:0'>$59,506</P>
</TD><TD valign=top style=width:72.95pt><P align=right style='font:10pt Times New Roman;margin:0'>$56,033</P>
</TD><TD valign=top style=width:70.9pt><P align=right style='font:10pt Times New Roman;margin:0'>$51,590</P>
</TD><TD valign=top style=width:70.85pt><P align=right style='font:10pt Times New Roman;margin:0'>$42,352</P>
</TD></TR>
<TR><TD valign=top style=width:203.85pt><P style='font:10pt Times New Roman;margin:0'> &nbsp;&nbsp;Accounts &amp; Other Receivables, Net</P>
</TD><TD valign=top style=width:68.8pt><P align=right style='font:10pt Times New Roman;margin:0'>4,606</P>
</TD><TD valign=top style=width:72.95pt><P align=right style='font:10pt Times New Roman;margin:0'>4,157</P>
</TD><TD valign=top style=width:70.9pt><P align=right style='font:10pt Times New Roman;margin:0'>4,104</P>
</TD><TD valign=top style=width:70.85pt><P align=right style='font:10pt Times New Roman;margin:0'>3,792</P>
</TD></TR>
<TR><TD valign=top style=width:203.85pt><P style='font:10pt Times New Roman;margin:0'> &nbsp;&nbsp;Inventories</P>
</TD><TD valign=top style=width:68.8pt><P align=right style='font:10pt Times New Roman;margin:0'>6,118</P>
</TD><TD valign=top style=width:72.95pt><P align=right style='font:10pt Times New Roman;margin:0'>5,975</P>
</TD><TD valign=top style=width:70.9pt><P align=right style='font:10pt Times New Roman;margin:0'>6,222</P>
</TD><TD valign=top style=width:70.85pt><P align=right style='font:10pt Times New Roman;margin:0'>6,580</P>
</TD></TR>
<TR><TD valign=top style=width:203.85pt><P style='font:10pt Times New Roman;margin:0'> &nbsp;&nbsp;Other Current Assets</P>
</TD><TD valign=top style=width:68.8pt><P align=right style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>357</FONT></P>
</TD><TD valign=top style=width:72.95pt><P align=right style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>451</FONT></P>
</TD><TD valign=top style=width:70.9pt><P align=right style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>346</FONT></P>
</TD><TD valign=top style=width:70.85pt><P align=right style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>393</FONT></P>
</TD></TR>
<TR><TD valign=top style=width:203.85pt><P style='font:10pt Times New Roman;margin:0'> &nbsp;&nbsp;&nbsp;&nbsp;Total Current Assets</P>
</TD><TD valign=top style=width:68.8pt><P align=right style='font:10pt Times New Roman;margin:0'>70,587</P>
</TD><TD valign=top style=width:72.95pt><P align=right style='font:10pt Times New Roman;margin:0'>66,616</P>
</TD><TD valign=top style=width:70.9pt><P align=right style='font:10pt Times New Roman;margin:0'>62,262</P>
</TD><TD valign=top style=width:70.85pt><P align=right style='font:10pt Times New Roman;margin:0'>53,117</P>
</TD></TR>
<TR><TD valign=top style=width:203.85pt><P style='font:10pt Times New Roman;margin:0'>Property &amp; Equipment, Net</P>
</TD><TD valign=top style=width:68.8pt><P align=right style='font:10pt Times New Roman;margin:0'>11,168</P>
</TD><TD valign=top style=width:72.95pt><P align=right style='font:10pt Times New Roman;margin:0'>11,087</P>
</TD><TD valign=top style=width:70.9pt><P align=right style='font:10pt Times New Roman;margin:0'>11,326</P>
</TD><TD valign=top style=width:70.85pt><P align=right style='font:10pt Times New Roman;margin:0'>10,812</P>
</TD></TR>
<TR><TD valign=top style=width:203.85pt><P style='font:10pt Times New Roman;margin:0'>Intangible Assets, Net</P>
</TD><TD valign=top style=width:68.8pt><P align=right style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>35,039</FONT></P>
</TD><TD valign=top style=width:72.95pt><P align=right style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>36,685</FONT></P>
</TD><TD valign=top style=width:70.9pt><P align=right style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>38,157</FONT></P>
</TD><TD valign=top style=width:70.85pt><P align=right style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>39,616</FONT></P>
</TD></TR>
<TR style=height:21.15pt><TD valign=top style=width:203.85pt><P style='font:10pt Times New Roman;margin:0'> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Assets</P>
</TD><TD valign=top style=width:68.8pt><P align=right style='font:10pt Times New Roman;margin:0'>$116,794</P>
</TD><TD valign=top style=width:72.95pt><P align=right style='font:10pt Times New Roman;margin:0'>$114,388</P>
</TD><TD valign=top style=width:70.9pt><P align=right style='font:10pt Times New Roman;margin:0'>$111,745</P>
</TD><TD valign=top style=width:70.85pt><P align=right style='font:10pt Times New Roman;margin:0'>$103,545</P>
</TD></TR>
<TR><TD valign=top style=width:203.85pt><P style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>Liabilities &amp; Stockholders&#8217; Equity</FONT></P>
</TD><TD valign=top style=width:68.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:72.95pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:70.9pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:70.85pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:203.85pt><P style='font:10pt Times New Roman;margin:0'>Accounts Payable</P>
</TD><TD valign=top style=width:68.8pt><P align=right style='font:10pt Times New Roman;margin:0'>1,186</P>
</TD><TD valign=top style=width:72.95pt><P align=right style='font:10pt Times New Roman;margin:0'>840</P>
</TD><TD valign=top style=width:70.9pt><P align=right style='font:10pt Times New Roman;margin:0'>788</P>
</TD><TD valign=top style=width:70.85pt><P align=right style='font:10pt Times New Roman;margin:0'>560</P>
</TD></TR>
<TR><TD valign=top style=width:203.85pt><P style='font:10pt Times New Roman;margin:0'>REPAT Tax Payable</P>
</TD><TD valign=top style=width:68.8pt><P align=right style='font:10pt Times New Roman;margin:0'>245</P>
</TD><TD valign=top style=width:72.95pt><P align=right style='font:10pt Times New Roman;margin:0'>79</P>
</TD><TD valign=top style=width:70.9pt><P align=right style='font:10pt Times New Roman;margin:0'>79</P>
</TD><TD valign=top style=width:70.85pt><P align=right style='font:10pt Times New Roman;margin:0;margin-left:18pt'>79 </P>
</TD></TR>
<TR><TD valign=top style=width:203.85pt><P style='font:10pt Times New Roman;margin:0'>Other Accrued Liabilities</P>
</TD><TD valign=top style=width:68.8pt><P align=right style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>3,000</FONT></P>
</TD><TD valign=top style=width:72.95pt><P align=right style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>3,648</FONT></P>
</TD><TD valign=top style=width:70.9pt><P align=right style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>2,924</FONT></P>
</TD><TD valign=top style=width:70.85pt><P align=right style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>2,604</FONT></P>
</TD></TR>
<TR><TD valign=top style=width:203.85pt><P style='font:10pt Times New Roman;margin:0'> &nbsp;&nbsp;Total Current Liabilities</P>
</TD><TD valign=top style=width:68.8pt><P align=right style='font:10pt Times New Roman;margin:0'> &nbsp;$4,431</P>
</TD><TD valign=top style=width:72.95pt><P align=right style='font:10pt Times New Roman;margin:0'> &nbsp;$4,567</P>
</TD><TD valign=top style=width:70.9pt><P align=right style='font:10pt Times New Roman;margin:0'> &nbsp;$3,791</P>
</TD><TD valign=top style=width:70.85pt><P align=right style='font:10pt Times New Roman;margin:0'> &nbsp;$3,243</P>
</TD></TR>
<TR><TD valign=top style=width:203.85pt><P style='font:10pt Times New Roman;margin:0'>Deferred Tax Liability &#8211;&nbsp;Intangible Assets</P>
</TD><TD valign=top style=width:68.8pt><P align=right style='font:10pt Times New Roman;margin:0'>2,355</P>
</TD><TD valign=top style=width:72.95pt><P align=right style='font:10pt Times New Roman;margin:0'>2,068</P>
</TD><TD valign=top style=width:70.9pt><P align=right style='font:10pt Times New Roman;margin:0'>2,151</P>
</TD><TD valign=top style=width:70.85pt><P align=right style='font:10pt Times New Roman;margin:0'>2,135</P>
</TD></TR>
<TR><TD valign=top style=width:203.85pt><P style='font:10pt Times New Roman;margin:0'>Long Term Lease Liability </P>
<P style='font:10pt Times New Roman;margin:0'>Long Term REPAT Tax Payable</P>
</TD><TD valign=top style=width:68.8pt><P align=right style='font:10pt Times New Roman;margin:0'>322</P>
<P align=right style='font:10pt Times New Roman;margin:0'>1,835</P>
</TD><TD valign=top style=width:72.95pt><P align=right style='font:10pt Times New Roman;margin:0'>329</P>
<P align=right style='font:10pt Times New Roman;margin:0'>1,995</P>
</TD><TD valign=top style=width:70.9pt><P align=right style='font:10pt Times New Roman;margin:0'>335</P>
<P align=right style='font:10pt Times New Roman;margin:0'>1,995</P>
</TD><TD valign=top style=width:70.85pt><P align=right style='font:10pt Times New Roman;margin:0;margin-left:36pt'>356</P>
<P style='font:10pt Times New Roman;margin:0;margin-left:36pt'>1,995</P>
</TD></TR>
<TR><TD valign=top style=width:203.85pt><P style='font:10pt Times New Roman;margin:0'>Deferred Revenue and Income Taxes</P>
</TD><TD valign=top style=width:68.8pt><P align=right style='font:10pt Times New Roman;margin:0'>486</P>
</TD><TD valign=top style=width:72.95pt><P align=right style='font:10pt Times New Roman;margin:0'>546</P>
</TD><TD valign=top style=width:70.9pt><P align=right style='font:10pt Times New Roman;margin:0'>651</P>
</TD><TD valign=top style=width:70.85pt><P align=right style='font:10pt Times New Roman;margin:0'>528</P>
</TD></TR>
<TR><TD valign=top style=width:203.85pt><P style='font:10pt Times New Roman;margin:0'>Stockholders&#8217; Equity</P>
</TD><TD valign=top style=width:68.8pt><P align=right style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>107,365</FONT></P>
</TD><TD valign=top style=width:72.95pt><P align=right style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>104,883</FONT></P>
</TD><TD valign=top style=width:70.9pt><P align=right style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>102,822</FONT></P>
</TD><TD valign=top style=width:70.85pt><P align=right style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>95,288</FONT></P>
</TD></TR>
<TR><TD valign=top style=width:203.85pt><P style='font:10pt Times New Roman;margin:0'> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Liabilities &amp; Stockholders&#8217; Equity</P>
</TD><TD valign=top style=width:68.8pt><P align=right style='font:10pt Times New Roman;margin:0'>$116,794</P>
</TD><TD valign=top style=width:72.95pt><P align=right style='font:10pt Times New Roman;margin:0'>$114,388</P>
</TD><TD valign=top style=width:70.9pt><P align=right style='font:10pt Times New Roman;margin:0'>$111,745</P>
</TD><TD valign=top style=width:70.85pt><P align=right style='font:10pt Times New Roman;margin:0'>$103,545</P>
</TD></TR>
</TABLE>
<HR style='border:0;height:0;width:0;margin:14pt 0 0 0'></DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>3
<FILENAME>utmd-20210722_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='iso-8859-1'?>
<!-- Produced by EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2021 [PPXK5GW761L0VF08S1AD]. www.edgarsuite.com -->
<link:linkbase xmlns="http://www.xbrl.org/2003/linkbase"
		xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
		xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"
		xmlns:fil="http://utahmed.com/20210722"
		xmlns:link="http://www.xbrl.org/2003/linkbase"
		xmlns:xlink="http://www.w3.org/1999/xlink"
		xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
		xmlns:xbrli="http://www.xbrl.org/2003/instance">
	<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
	<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
	<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
	<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
	<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
	<link:roleRef roleURI="http://utahmed.com/20210722/role/idr_DocumentDocumentAndEntityInformation" xlink:type="simple" xlink:href="utmd-20210722.xsd#idr_DocumentDocumentAndEntityInformation"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://utahmed.com/20210722/role/idr_DocumentDocumentAndEntityInformation"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>utmd-20210722_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='iso-8859-1'?>
<!-- Produced by EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2021 [PPXK5GW761L0VF08S1AD]. www.edgarsuite.com -->
<link:linkbase xmlns="http://www.xbrl.org/2003/linkbase"
		xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
		xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"
		xmlns:fil="http://utahmed.com/20210722"
		xmlns:link="http://www.xbrl.org/2003/linkbase"
		xmlns:xlink="http://www.w3.org/1999/xlink"
		xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
		xmlns:xbrli="http://www.xbrl.org/2003/instance">
	<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
	<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
	<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
	<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
	<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
	<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
	<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel"/>
	<link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber' xlink:label='dei_EntityFileNumber'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityFileNumber' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity File Number</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityFileNumber' xlink:to='lab_dei_EntityFileNumber'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName' xlink:label='dei_SecurityExchangeName'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_SecurityExchangeName' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Trading Exchange</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_SecurityExchangeName' xlink:to='lab_dei_SecurityExchangeName'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey' xlink:label='dei_EntityCentralIndexKey'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityCentralIndexKey' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Registrant CIK</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityCentralIndexKey' xlink:to='lab_dei_EntityCentralIndexKey'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications' xlink:label='dei_WrittenCommunications'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_WrittenCommunications' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Written Communications</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_WrittenCommunications' xlink:to='lab_dei_WrittenCommunications'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType' xlink:label='dei_DocumentType'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_DocumentType' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>SEC Form</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_DocumentType' xlink:to='lab_dei_DocumentType'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode' xlink:label='dei_CityAreaCode'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_CityAreaCode' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>City Area Code</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_CityAreaCode' xlink:to='lab_dei_CityAreaCode'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown' xlink:label='dei_EntityAddressCityOrTown'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityAddressCityOrTown' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Address, City or Town</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityAddressCityOrTown' xlink:to='lab_dei_EntityAddressCityOrTown'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer' xlink:label='dei_PreCommencementIssuerTenderOffer'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_PreCommencementIssuerTenderOffer' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Pre-commencement Issuer Tender Offer</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_PreCommencementIssuerTenderOffer' xlink:to='lab_dei_PreCommencementIssuerTenderOffer'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod' xlink:label='dei_EntityExTransitionPeriod'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityExTransitionPeriod' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Ex Transition Period</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityExTransitionPeriod' xlink:to='lab_dei_EntityExTransitionPeriod'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer' xlink:label='dei_EntityWellKnownSeasonedIssuer'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityWellKnownSeasonedIssuer' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Well-known Seasoned Issuer</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityWellKnownSeasonedIssuer' xlink:to='lab_dei_EntityWellKnownSeasonedIssuer'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany' xlink:label='dei_EntityEmergingGrowthCompany'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityEmergingGrowthCompany' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Emerging Growth Company</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityEmergingGrowthCompany' xlink:to='lab_dei_EntityEmergingGrowthCompany'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany' xlink:label='dei_EntityShellCompany'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityShellCompany' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Shell Company</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityShellCompany' xlink:to='lab_dei_EntityShellCompany'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate' xlink:label='dei_CurrentFiscalYearEndDate'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_CurrentFiscalYearEndDate' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Fiscal Year End</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_CurrentFiscalYearEndDate' xlink:to='lab_dei_CurrentFiscalYearEndDate'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer' xlink:label='dei_PreCommencementTenderOffer'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_PreCommencementTenderOffer' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Pre-commencement Tender Offer</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_PreCommencementTenderOffer' xlink:to='lab_dei_PreCommencementTenderOffer'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness' xlink:label='dei_EntitySmallBusiness'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntitySmallBusiness' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Small Business</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntitySmallBusiness' xlink:to='lab_dei_EntitySmallBusiness'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode' xlink:label='dei_EntityIncorporationStateCountryCode'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityIncorporationStateCountryCode' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Incorporation, State or Country Code</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityIncorporationStateCountryCode' xlink:to='lab_dei_EntityIncorporationStateCountryCode'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial' xlink:label='dei_SolicitingMaterial'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_SolicitingMaterial' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Soliciting Material</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_SolicitingMaterial' xlink:to='lab_dei_SolicitingMaterial'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentDescription' xlink:label='dei_AmendmentDescription'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_AmendmentDescription' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Amendment Description</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_AmendmentDescription' xlink:to='lab_dei_AmendmentDescription'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers' xlink:label='dei_EntityVoluntaryFilers'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityVoluntaryFilers' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Voluntary filer</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityVoluntaryFilers' xlink:to='lab_dei_EntityVoluntaryFilers'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName' xlink:label='dei_EntityRegistrantName'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityRegistrantName' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Registrant Name</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityRegistrantName' xlink:to='lab_dei_EntityRegistrantName'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat' xlink:label='dei_EntityPublicFloat'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityPublicFloat' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Public Float</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityPublicFloat' xlink:to='lab_dei_EntityPublicFloat'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol' xlink:label='dei_TradingSymbol'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_TradingSymbol' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Trading Symbol</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_TradingSymbol' xlink:to='lab_dei_TradingSymbol'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber' xlink:label='dei_LocalPhoneNumber'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_LocalPhoneNumber' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Local Phone Number</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_LocalPhoneNumber' xlink:to='lab_dei_LocalPhoneNumber'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_TextBlockAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Details</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_TextBlockAbstract' xlink:to='lab_us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag' xlink:label='dei_AmendmentFlag'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_AmendmentFlag' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Amendment Flag</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_AmendmentFlag' xlink:to='lab_dei_AmendmentFlag'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode' xlink:label='dei_EntityAddressPostalZipCode'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityAddressPostalZipCode' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Address, Postal Zip Code</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityAddressPostalZipCode' xlink:to='lab_dei_EntityAddressPostalZipCode'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory' xlink:label='dei_EntityFilerCategory'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityFilerCategory' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Filer Category</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityFilerCategory' xlink:to='lab_dei_EntityFilerCategory'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber' xlink:label='dei_EntityTaxIdentificationNumber'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityTaxIdentificationNumber' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Tax Identification Number (TIN)</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityTaxIdentificationNumber' xlink:to='lab_dei_EntityTaxIdentificationNumber'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1' xlink:label='dei_EntityAddressAddressLine1'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityAddressAddressLine1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Address, Address Line One</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityAddressAddressLine1' xlink:to='lab_dei_EntityAddressAddressLine1'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent' xlink:label='dei_EntityInteractiveDataCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityInteractiveDataCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Interactive Data Current</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityInteractiveDataCurrent' xlink:to='lab_dei_EntityInteractiveDataCurrent'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince' xlink:label='dei_EntityAddressStateOrProvince'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityAddressStateOrProvince' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Address, State or Province</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityAddressStateOrProvince' xlink:to='lab_dei_EntityAddressStateOrProvince'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus' xlink:label='dei_EntityCurrentReportingStatus'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityCurrentReportingStatus' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Current with reporting</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityCurrentReportingStatus' xlink:to='lab_dei_EntityCurrentReportingStatus'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding' xlink:label='dei_EntityCommonStockSharesOutstanding'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityCommonStockSharesOutstanding' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Number of common stock shares outstanding</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityCommonStockSharesOutstanding' xlink:to='lab_dei_EntityCommonStockSharesOutstanding'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate' xlink:label='dei_DocumentPeriodEndDate'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_DocumentPeriodEndDate' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Period End date</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_DocumentPeriodEndDate' xlink:to='lab_dei_DocumentPeriodEndDate'/>
	</link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>utmd-20210722_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='iso-8859-1'?>
<!-- Produced by EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2021 [PPXK5GW761L0VF08S1AD]. www.edgarsuite.com -->
<link:linkbase xmlns="http://www.xbrl.org/2003/linkbase"
		xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
		xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"
		xmlns:fil="http://utahmed.com/20210722"
		xmlns:link="http://www.xbrl.org/2003/linkbase"
		xmlns:xlink="http://www.w3.org/1999/xlink"
		xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
		xmlns:xbrli="http://www.xbrl.org/2003/instance">
	<link:roleRef roleURI="http://utahmed.com/20210722/role/idr_DocumentDocumentAndEntityInformation" xlink:type="simple" xlink:href="utmd-20210722.xsd#idr_DocumentDocumentAndEntityInformation"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://utahmed.com/20210722/role/idr_DocumentDocumentAndEntityInformation">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey' xlink:label='dei_EntityCentralIndexKey'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityCentralIndexKey' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate' xlink:label='dei_CurrentFiscalYearEndDate'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_CurrentFiscalYearEndDate' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName' xlink:label='dei_EntityRegistrantName'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityRegistrantName' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType' xlink:label='dei_DocumentType'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_DocumentType' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate' xlink:label='dei_DocumentPeriodEndDate'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_DocumentPeriodEndDate' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol' xlink:label='dei_TradingSymbol'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_TradingSymbol' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName' xlink:label='dei_SecurityExchangeName'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_SecurityExchangeName' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber' xlink:label='dei_EntityTaxIdentificationNumber'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityTaxIdentificationNumber' use='optional' order='8.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding' xlink:label='dei_EntityCommonStockSharesOutstanding'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityCommonStockSharesOutstanding' use='optional' order='9.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat' xlink:label='dei_EntityPublicFloat'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityPublicFloat' use='optional' order='10.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory' xlink:label='dei_EntityFilerCategory'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityFilerCategory' use='optional' order='11.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus' xlink:label='dei_EntityCurrentReportingStatus'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityCurrentReportingStatus' use='optional' order='12.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent' xlink:label='dei_EntityInteractiveDataCurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityInteractiveDataCurrent' use='optional' order='13.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers' xlink:label='dei_EntityVoluntaryFilers'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityVoluntaryFilers' use='optional' order='14.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer' xlink:label='dei_EntityWellKnownSeasonedIssuer'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityWellKnownSeasonedIssuer' use='optional' order='15.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany' xlink:label='dei_EntityShellCompany'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityShellCompany' use='optional' order='16.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness' xlink:label='dei_EntitySmallBusiness'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntitySmallBusiness' use='optional' order='17.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany' xlink:label='dei_EntityEmergingGrowthCompany'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityEmergingGrowthCompany' use='optional' order='18.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod' xlink:label='dei_EntityExTransitionPeriod'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityExTransitionPeriod' use='optional' order='19.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentDescription' xlink:label='dei_AmendmentDescription'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_AmendmentDescription' use='optional' order='20.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode' xlink:label='dei_EntityIncorporationStateCountryCode'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityIncorporationStateCountryCode' use='optional' order='21.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber' xlink:label='dei_EntityFileNumber'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityFileNumber' use='optional' order='22.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1' xlink:label='dei_EntityAddressAddressLine1'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityAddressAddressLine1' use='optional' order='23.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown' xlink:label='dei_EntityAddressCityOrTown'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityAddressCityOrTown' use='optional' order='24.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince' xlink:label='dei_EntityAddressStateOrProvince'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityAddressStateOrProvince' use='optional' order='25.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode' xlink:label='dei_EntityAddressPostalZipCode'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityAddressPostalZipCode' use='optional' order='26.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode' xlink:label='dei_CityAreaCode'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_CityAreaCode' use='optional' order='27.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber' xlink:label='dei_LocalPhoneNumber'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_LocalPhoneNumber' use='optional' order='28.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications' xlink:label='dei_WrittenCommunications'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_WrittenCommunications' use='optional' order='29.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial' xlink:label='dei_SolicitingMaterial'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_SolicitingMaterial' use='optional' order='30.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer' xlink:label='dei_PreCommencementTenderOffer'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_PreCommencementTenderOffer' use='optional' order='31.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer' xlink:label='dei_PreCommencementIssuerTenderOffer'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_PreCommencementIssuerTenderOffer' use='optional' order='32.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag' xlink:label='dei_AmendmentFlag'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_AmendmentFlag' use='optional' order='33.0'/>
	</link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>utmd-20210722.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='iso-8859-1'?>
<!-- Produced by EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2021 [PPXK5GW761L0VF08S1AD]. www.edgarsuite.com -->
<schema xmlns='http://www.w3.org/2001/XMLSchema' xmlns:us-gaap='http://fasb.org/us-gaap/2020-01-31' xmlns:fil='http://utahmed.com/20210722' xmlns:dei='http://xbrl.sec.gov/dei/2020-01-31' xmlns:xlink='http://www.w3.org/1999/xlink' xmlns:xbrldt='http://xbrl.org/2005/xbrldt' targetNamespace='http://utahmed.com/20210722' xmlns:link='http://www.xbrl.org/2003/linkbase' xmlns:xbrli='http://www.xbrl.org/2003/instance' elementFormDefault='qualified' attributeFormDefault='unqualified'>
	<annotation>
		<appinfo>
			<link:linkbaseRef xlink:type="simple" xlink:href="utmd-20210722_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
			<link:linkbaseRef xlink:type="simple" xlink:href="utmd-20210722_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
			<link:linkbaseRef xlink:type="simple" xlink:href="utmd-20210722_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
			<link:roleType roleURI="http://utahmed.com/20210722/role/idr_DocumentDocumentAndEntityInformation" id="idr_DocumentDocumentAndEntityInformation">
				<link:definition>000010 - Document - Document and Entity Information</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
		</appinfo>
	</annotation>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd' namespace='http://www.xbrl.org/dtr/type/numeric'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd' namespace='http://www.xbrl.org/dtr/type/non-numeric'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2005/xbrldt-2005.xsd' namespace='http://xbrl.org/2005/xbrldt'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd' namespace='http://www.xbrl.org/dtr/type/numeric'/>
	<import schemaLocation='http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd' namespace='http://www.xbrl.org/dtr/type/non-numeric'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd' namespace='http://www.xbrl.org/dtr/type/numeric'/>
	<import schemaLocation='http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd' namespace='http://www.xbrl.org/dtr/type/non-numeric'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2005/xbrldt-2005.xsd' namespace='http://xbrl.org/2005/xbrldt'/>
	<import schemaLocation='http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd' namespace='http://www.xbrl.org/dtr/type/non-numeric'/>
	<import schemaLocation='http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd' namespace='http://www.xbrl.org/dtr/type/numeric'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd' namespace='http://www.xbrl.org/dtr/type/numeric'/>
	<import schemaLocation='http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd' namespace='http://www.xbrl.org/dtr/type/non-numeric'/>
	<import schemaLocation='http://www.xbrl.org/2005/xbrldt-2005.xsd' namespace='http://xbrl.org/2005/xbrldt'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd' namespace='http://www.xbrl.org/dtr/type/non-numeric'/>
	<import schemaLocation='http://www.xbrl.org/2005/xbrldt-2005.xsd' namespace='http://xbrl.org/2005/xbrldt'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd' namespace='http://www.xbrl.org/dtr/type/non-numeric'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd' namespace='http://www.xbrl.org/dtr/type/non-numeric'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2005/xbrldt-2005.xsd' namespace='http://xbrl.org/2005/xbrldt'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd' namespace='http://www.xbrl.org/dtr/type/non-numeric'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd' namespace='http://www.xbrl.org/dtr/type/non-numeric'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd' namespace='http://www.xbrl.org/dtr/type/non-numeric'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import namespace='http://fasb.org/us-gaap/2020-01-31' schemaLocation='http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd' />
	<import namespace='http://xbrl.sec.gov/dei/2020-01-31' schemaLocation='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd' />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>utmd-20210722_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="utmd-20210722.xsd" xlink:type="simple"/>
    <context id="D210722">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000706698</identifier>
        </entity>
        <period>
            <startDate>2021-07-22</startDate>
            <endDate>2021-07-22</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="D210722" id="fact1">0000706698</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="D210722" id="fact2">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="D210722">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="D210722">2021-07-22</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="D210722">UTAH MEDICAL PRODUCTS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="D210722">UT</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="D210722">000-12575</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="D210722">87-0342734</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="D210722">7043 South 300 West</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="D210722">Midvale</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="D210722">UT</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="D210722">84047</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="D210722">801</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="D210722">566-1200</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="D210722">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="D210722">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="D210722">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="D210722">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany contextRef="D210722">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139809952697112">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jul. 22, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TextBlockAbstract', window );"><strong>Details</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Registrant CIK</a></td>
<td class="text">0000706698<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">UTAH MEDICAL PRODUCTS, INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">SEC Form</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Period End date</a></td>
<td class="text">Jul. 22,  2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Tax Identification Number (TIN)</a></td>
<td class="text">87-0342734<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">UT<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-12575<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">7043 South 300 West<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Midvale<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">UT<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">84047<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">801<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">566-1200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M              "  <T!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%
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M+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( #-G]E(D'INBK0   /@!   :
M          "  4$1  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4
M Q0    ( #-G]E)ED'F2&0$  ,\#   3              "  282  !;0V]N
E=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  ' 3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>96</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="utmd-20210722.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000010 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://utahmed.com/20210722/role/idr_DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="utmd-20210722.htm">utmd-20210722.htm</File>
    <File>utah_ex99z1.htm</File>
    <File>utmd-20210722.xsd</File>
    <File>utmd-20210722_def.xml</File>
    <File>utmd-20210722_lab.xml</File>
    <File>utmd-20210722_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "utmd-20210722.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "definitionLink": {
     "local": [
      "utmd-20210722_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "utmd-20210722.htm"
     ]
    },
    "labelLink": {
     "local": [
      "utmd-20210722_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "utmd-20210722_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "utmd-20210722.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 34,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2020-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 96,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "fil",
   "nsuri": "http://utahmed.com/20210722",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "b",
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "utmd-20210722.htm",
      "contextRef": "D210722",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000010 - Document - Document and Entity Information",
     "role": "http://utahmed.com/20210722/role/idr_DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "b",
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "utmd-20210722.htm",
      "contextRef": "D210722",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20210722/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20210722/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20210722/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Fiscal Year End"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20210722/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Period End date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20210722/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "SEC Form"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20210722/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20210722/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20210722/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20210722/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20210722/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Registrant CIK"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20210722/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Number of common stock shares outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20210722/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Current with reporting"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20210722/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20210722/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20210722/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20210722/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20210722/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20210722/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20210722/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20210722/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20210722/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20210722/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20210722/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Tax Identification Number (TIN)"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20210722/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Voluntary filer"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20210722/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20210722/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20210722/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20210722/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20210722/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Trading Exchange"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20210722/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20210722/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20210722/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20210722/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "us-gaap_TextBlockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Details"
       }
      }
     },
     "localname": "TextBlockAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r4": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r5": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r7": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001096906-21-001665-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001096906-21-001665-xbrl.zip
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MYI&!0D?.$RH\4 M3X**FU!: LUD$>.S[\+6/K?HQ#('3Y"%Z&3 5. ##/5"
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M&Z15=1ZG>"E+S[?M-W[V^MI'IY'(L/#0F2A<<'E'GO!W\>0#HX?6@X#=<7=
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M?I(Q$#I",SY5L,4O 39JFL5!=J_@4;F#1P-QMU3!?$O<2],[R4[OI358E[V
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MDY02_^&$,A[(8  ZH*/JQ)&%MXDP-J"U< *]CA$56"009QSWL['<X\' IR
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MV J6W64S'>DMY(F=3_A-^X3SM'RF.MZJ_?'=H6V5CB11S&-!7_B,^#H!M4]
M#W@1CD1HR*AFX''!P,Y8;<187>,*5%(_9>\E?P7=HQHLSN)&RWRFYD*/\?Y%
MY^A<.-33""Z1_"X>'!B6;9K?AZ'<*<7-*\4-%L2L4$GFY^BX#.S;*#G!(F\6
M)C4GH0Y0X)'&+AZH]2Z)2]U<(C&N(1Z5:4W84P<EIVN<-EY)M:):'<&J]YGS
M1=?TT0""+W!B<:^J(QY(AWGB'B>-+T?U[W'M.^$2K)QBO@O$4 +H,8@\17TF
M(ND-B:2*R^Y0]TPZB Z,FR3K8Y 3)3T1P %"^\/T75=X,#CVPX"0XQZ/K*QG
MPE/"]&+),M:=+5*K-JY/F\W,ME8;JYO"T11F&II/(5>P*+@Q%OE)'EHN&'YW
MA/ Z%,BN8/&13.52H7"T:AZJ4#37--ED3C")R4F18*)0M17! A7L8L)'CPI4
ML2YUSRJ1^EF+V'DS"PU7R,NO;?&6LS7KH^.JU3^;Y]H;X7$'ULKO78#N 07D
M?>,L.YX0&20S>LJO5H&"?S?!LE.%U".&+9C9N.6.9[>)9Z]#AEH6SP+IXPIH
M"<.K;G>F<_^M\"Y,S' F9O:BWK4*KF'O==XOQLEQVQTO;S$O-Z6,6/AOYN@\
M,PI[SF(<G;3=<?3, ,^>&^"5#K.':\&FZ;NXI S/%#LZJ('F7\A]G^FBNT<1
M!\0OU"? #PBQ1WJAN%=]Y(P HQ JB<NZW(\/&,3NI5E\YO#3^,Q3GNREYZ6T
MDYDVY_IP0H"'$S"FC!G,[ACV@D>I)L BNXU[3@#._GN83T?&F6ICQL*]L&65
M=ON@>]7C3IM2;V\E#5]1$$'JNG/D"#/ASPHE?Y(!Z(/(,0\X'43.%UH71Y+I
M5K R29X!KT7@6A;BX\FX1GHL;XB#WW,8&KG !T3A3<CNN(1^(,C4=] )IXZ#
M)P&P<7Q11NC*.,. \(-GSS[NT=&IQTGYS)+?8[+'__XQ.__S=N>BQQT#VF-&
M)V3TBT&[H"(JU+NG0WGT&& >!N]0YPNL&Q@[3&N(L/*N;.*?=(Q#'&+JV#5>
M5&&,4!HS0TR#=1WK7G0'8Y&TV/Q-G>-.M=EN7! [:]IZ6\<^:C5N;L_;-^3J
MC%Q=-UJU=O/J,C[1?=:\K%W6F[5S4K^Z/&VVYYWH7N,!S+D9V$F&*IO(1#6E
M* B<2\#V,>!GBM:ESSM<D7(Y:X&8H&E+2VCCFSA&MQOH3GBR3D[(#O='-Y)H
MN</J#'+!4+Z]Y$(/E5S-H=^CP*A^R!C1!UE!O+40_Q;YC.3-^!2K1@,:WX,@
M&IX07Q+)5-I1DX"11[6TP@Q&[3ML*. 71<EE$BFGK335C[H/HZ Z7#VMJ4.S
MZ?'X-J V.1WHK>UIG,HEL@]J'H8!'P#PF$<G[B-I_>%(DVEPHPDDQ(>!=#X9
MG[0T8DX40,W,5B4>Q3[.D0XTW?9!#3HLT+III!3AJ4\!W\CI3\]'PG>@(D'Y
MQ1A/OJ2Z6(%"BXYD?T<(19]VUJ!T6A<W+V.: M(O3%Z/_?SLLV0A.J.V!UHK
MH T.065"'>0AT,B!D$PNZ"M-$BS[*H%\K4[9C'XJ9TTKT4]C+:3OL+AH7+;3
M"R=^;?[2;-^\6B=MA 3MJ=P^3]>:QMYXHJ TBX_89'KG?)V365_V/S7@I8/)
MD^JSG:UB>7JW\*4=Q,1N&QVAE!A4S"Q>X2&%QUWRSM0_K][\ AY+#,0LSED!
M8KS=_=.C?<"7MGZWN, \;Y>70N\-%FZV=*RP8&V\T0K5:7IQQ?>S= ?6ULG<
M6I<.BTS0RL[;=%^?1EI#F3,8-7 4M#OZEESV2INQ=A6Q!@3GU$8=)2$=\NO9
MV2.>MH*'28X^.P-0E*07H]'^G^RA7/['RO;58#1)/;[+G.3D77(GW=FZPX3C
M'%T5EU&$\0H8\14[*W=_'->\ M1+(=%KL9P13;T"[-Q [!5P]\?S3<K?YI4$
M9I<_';#5:F59\[4)!+?6EBQ=7?BU*?D5+<CW1JVO(!CM?ARY<KP$=B<=.^G8
M7FIMC]E8?3]D:82XCR?Q*X:%Q<.3P/47S^'\YV(_RX5J!BQ'Y6",0AI)+HK4
M\9>..]K0$?'.5X5VP&./%#MZ:7 -6Y,@4_WI. >PJC7/2Y-L$H^F) =6P#O3
M6V?HBL??H ?G,'V"!;\$5XP/M&^O=_/2KVD0>/",^3&\%7N<&4Z @!NI([P#
M,T[<3\ ?YP#GP(_3TPY+L[\!#15W(H^&Q$W2$]G5DH-S5F9%!EI#CG+R$N'F
MA\M:^[;5V-(T[N0ML?%&[M\1#Y,(9=%<_3,[P"X&"0Z-<-=V<J< AND /P .
M\$+$5SYV6)]Z7=R20$!Z+R5I@/LL$6Y.:' T4GT10F"PB2V!-RX@SQ>RYN:L
MR&*% G:A\(Q)>>Y4QOKR&YWY]YVNDO#ZM])RY3+$';UV]/HVZ(5W;+L50AY=
MF+V8PVP?3%%G\P3[95A9&#?K4--HA:V)Y?'*R1SYR.[ B3O/DKH(_7OF>5LG
M!UNTD$NB]V@MT2/=S$(^6<1]4N]SU@6W++VFXDI?4_'TUK^O4,.6C)1+_A<<
M_1_I5'_X/U!+ P04    "  S9_92UEZ3I=X#  #Q@@  $0   '5T;60M,C R
M,3 W,C(N>'-D[=Q;;]LV% ?PY^93<'[1!H2Z.$@;![:+H&F+8&D7I+L4&(:"
MEBB;F$2J)&4GW[Z4;-E.?%F"K8L#__,2R>0YO\.K\Y3NZYL\(V.NC5"RYT5^
MZ!$N8Y4(.>QYPBAZ<G+<H9'WNG_0_8%2<J554L8\(8-;\O;\_=FU*87EQ*C4
M3ICFA^0L&3-9=7BC\J*T7),+*=6860>80_<2^X>NK;C58CBRY,<W/Y%V&)[0
M=MB.R)]75Y]_/G[_QZN7T67X^[OPY%-T=OZ73R:3B<^3(=.UYL<J)Y2ZBDP\
MXCDC;@S2]+R1M<5I$%2=)T>^TL/ 98Z"SQ\N/]7]O&G'T]+0(6/%/"!E9E!W
MGS6XL'9(PX@>14U(*K)Y]]*R4<Z3JHJJ9Q2^:K>;?@D7\WXW YWYAL?^4(T#
MU[ F[4TFY-_K"H\ZG4Y0M\Z[NFR)O9M\-L3C8-KH$<OTD-N/+.>F8#%_4,DK
M)2RG/@JJY@$S?+D.L:6_D,96&\#MHXSG7-IW2N?G/&5EYJK_6K),I((G'F'6
M:C%P.^1.AU(NNO0/7G29VSRVWCSNS;T6A9"IJIY?=*O23IOZKGE*Z@D[M;<%
M[[6,R(N,MV:?C31/>ZW2Y@EMQO^ET-QW8VJZ:)6YL(WCJIH#%V+<D.IZ+A=P
MDX+I>"7+RH*Z)*K@V@INYI/;"OZ3$24\?>R(7(B08D?'D['!8\?C0GCVW892
MI?C5%4^JA]^N+^;IUAVP:4$BT5_.55Q61Z'Y?2:3M](*>WOA]K+.Z^W4(B+I
MM1[<NRYJ5M5B#?NA^XE"0DD3O/S(9$*FF<A2JFYP/\E2ZM+PY!?9KY_O;_Y9
MX*S+AJ"[^^M!(3'+XC+;PLP^:1:COAB"Q<W@GI<OC:[;9DI;,OVNN%1QW;#E
M!JO>:'.-T>HC&K7=I>W?&'=MR97+=<L=&#S23ZP.JL,12+=B6L25WJGTZ.6#
M]/OQCRY@=R9 R8__=@Z4I,]U'I:^U2OX>!.Y]L^ 9SC8'=ET3W3JL.NQ$#NU
M$/_K];,KD_[DNV\'5AW^'OM/?@!VY2; 7U_PX<.'#Q\^?/CPX<.'#Q\^?/CP
MX<.'#Q\^?/CPX<.'#Q\^?/CPX<.'#Q\^?/CPX<.'#Q\^?/CPX<.'#Q\^?/CP
MX<.'#Q\^?/CPX<.'#Q\^?/CPX<.'#Q\^?/CPX<.'#Q\^?/CPGZV/?_J]AXL.
M'X=N%^8!_G[[. ?X\H./0[>7ZP ?/NZ!IY\'^/OMXQS _][^:F#*S* .*@T=
M,E:XX'9(P\A9WJ9R:VAM8, S:YI/Z"+5M.SME=19#8_]H1H'"1?_6(G9%%0]
MK,.[P31-_^ ;4$L#!!0    ( #-G]E+8.#V0%@(  "8'   5    =71M9"TR
M,#(Q,#<R,E]D968N>&ULK95=;]HP%(:OX5=X[()-PG$2Q H(J%#I*C0F(:IM
ME:9I"O$)L1;;R';X^/>S4P)EM%LGN %\_/H]SWGS0>]ZPS.T J69%/UZX/EU
M!"*6E(E%O\ZTQ.UVJX.#^O6@VGN#,9HJ2?,8*)IOT>WH;CC3.3. M$S,.E+0
M0$.ZBH03W$B^S TH-!9"KB)C&^B&7<1>P^XMMXHM4H/>W;Q'H>^W<>B' ?H^
MG3Y\:MU]N_H03/RO'_WV?3 <_?#0>KWV@"XB573S8LD1QI8H8^)7UWW,(PW(
MCB)TOY8:L^P2XLYLYBKSI%H0VZ))2F&M6JD4VNY&LR/]NEFJ _+P>7(?I\ C
MS(0V;J;BG&9=790G,BZ&>D5#]*+"K7 IPZZ$@Q W V^CZ0$S8=F^2VZBE -U
M&1"7F7\5A@>EL_J_!$Y.[#((.IT.*7:?B*T9-7OU4^\6>=P\%K._L.Q3'50K
MCQ<R4K&2&<P@0;N?7V;CTVY,&$(9)SL-B;*LA@K2KMDNH5_3C"\S*&NI@N1%
MC!+;1=]RH;]U;N1<I-1RJ#B? [95$.[ANB#B<^YG(^^M,(4DRC-S0>!3[TOB
M2AZQ2\9[8GT^;.&#.? YJ$N2'OD>,$O&/P&?>W>0@I!1]7,DX]Q.;LKOH:"W
MPC"S'8M$*EZ\[/X-GQM.<6E>4+[:^S" O4V88*XXL<NCGK Q("C0LJO#O^2
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MZWDQH-B[#%P.V2*J:*<L.]E=]G9^-OR!^NYX*[N"D]]H.][Z%U!+ P04
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MHF;1?>8TT=A$=KW"E\*NKA;H]\P!S)V5KUE87S"E'QA?L1%&DC,<#:1,#DQ
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MWV#^F/^+N3KZ%U!+ 0(4 Q0    ( #-G]E(DP?;X"3T  +/A 0 /
M      "  0    !U=&%H7V5X.3EZ,2YH=&U02P$"% ,4    "  S9_92O%UO
MZ9(.  #_:@  $0              @ $V/0  =71M9"TR,#(Q,#<R,BYH=&U0
M2P$"% ,4    "  S9_92UEZ3I=X#  #Q@@  $0              @ 'W2P
M=71M9"TR,#(Q,#<R,BYX<V102P$"% ,4    "  S9_92V#@]D!8"   F!P
M%0              @ $$4   =71M9"TR,#(Q,#<R,E]D968N>&UL4$L! A0#
M%     @ ,V?V4H0CL!HL"   G4\  !4              ( !35(  '5T;60M
M,C R,3 W,C)?;&%B+GAM;%!+ 0(4 Q0    ( #-G]E(.PY..K 4  !$U   5
M              "  :Q:  !U=&UD+3(P,C$P-S(R7W!R92YX;6Q02P4&
/  8 !@"$ 0  BV

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
